pharmaceutical brands 52 - mediaquant · 56 +3 +5% +13 +12% purdue pharma 42-6 -13% 602 ... for the...

Pharmaceutical Brands

November2016

Media Cycle: Oct 1 - 31, 2016

52

© Copyright 2016 mediaQuant, Inc.

uantThe numbers behind the news

Qmedia

This free report provides

media prominence metrics for

the top 15 entities in the

sector. For full analytics on all

sector entities, subscribe to

mediaQuant dashboards via a

free trial at mediaQuant.net

© Copyright 2016 mediaQuant, Inc.The numbers behind the news

Contact mediaQuant

License our Content

For reprint permission for this report or its data elements, please contact Mary Senatori. To order full versions of this report in online or printed format,

please visit www.mediaquant.net.

Mary Senatori

[email protected]

www.mediaquant.net

Portland, OR 97212

About mediaQuantmediaQuant, Inc. provides businesses with analytic insight into how their brands, competitors, and

market influencers are trending in earned media. We represent earned media coverage as a simple,

comparative metric and publish it across a growing catalog of thousands of business and consumer

topics, trends, brands, and influencers discussed in traditional and social media. Using our online

dashboards, companies can benchmark the media performance of their brands alongside competitors,

track the key issues and influencers driving mindshare and market share, monitor and compare media

momentum over time, within peer groups, and across multiple traditional and social media segments,

and assign advertising value to earned media for their brand. For more information or a free 30-day trial

subscription, visit www.mediaquant.net.

Total Listing 58

Advances 27

Declines 27 Johnson and Johnson 84 +1 1% 337,562

Unchanged 4 Pfizer 80 -2 -2% 1,218

Novartis 73 -2 -3% 1,000

Janssen Pharmaceuticals 64 +1 2% 970

Baxter International 63 +4 7% 892

59 +5 +8% -7 -12% Bristol-Myers Squibb 70 +6 9% 878

39 +3 +8% +9 +15% Sanofi 74 -1 -1% 685

49 +3 +6% -2 -4% Bayer HealthCare 70 -6 -8% 606

56 +3 +5% +13 +12% Purdue Pharma 42 -6 -13% 602

59 +2 +3% -4 -8% Kite Pharma 48 -3 -6% 594

61 +2 +3% +2 +5% AstraZeneca 73 +2 3% 553

66 +2 +3% +3 +2% UCB 48 -1 -2% 518

68 +2 +3% +7 +6% Novo Nordisk 67 -1 -1% 513

36 +1 +3% +2 +6% Amgen 67 -3 -4% 490

38 +1 +3% +3 -3% GlaxoSmithKline 70 -3 -4% 466

39 +1 +3% +4 +3% Endo 43 -3 -7% 451

46 +1 +2% +10 +15% Teva 68 -2 -3% 413

48 +1 +2% -1 - Forest Laboratories 42 -9 -18% 411

49 +1 +2% +5 +4% Eli Lilly 68 +2 3% 409

YTD

ChgMost Dynamic Sectors* Close Chg.

12 mo

Chg

Science Trends

Children & Youth Advocacy Groups

NHL Teams

Quick Service Brands

Financial Services Brands

Teens and Children Trends

Online Payment Brands

Car Sharing Brands

Ground Transportation

Health & Wellness Advocacy

Online Retailers

NBA Teams

Philanthropic Foundations

NBA Players

52 -1 -420 MOST ACTIVE

MOST ACTIVE, TOP GAINERS AND TOP LOSERS

Pharmaceutical Brands Sector● New High (Media Rating)

Sector

Media Rating

Prior Mo.

Change

Prior Yr.

Change

Sector

Close

Rating

Chg. % Chg.

MentionVolume

(100)

%Chg

49 +1 +2% +5 +4% Eli Lilly 68 +2 3% 409

51 +1 +2% +8 +21% Valeant 63 -4 -6% 390

Close % Chg. Close % Chg.

Mentions

(100)

20 TOP GAINERS 20 TOP LOSERS

Hospira 49 +10 26% Juno Therapeutics 36 -11 -23% 40

CSL Limited 45 +7 18% Forest Laboratories 42 -9 -18% 411

Bristol-Myers Squibb 70 +6 9% Takeda 52 -7 -12% 127

Actavis 57 +5 10% Bayer HealthCare 70 -6 -8% 606

Daiichi Sankyo 49 +5 11% Allergan 68 -6 -8% 358

Baxter International 63 +4 7% Purdue Pharma 42 -6 -13% 602

Celgene 60 +4 7% Lundbeck 41 -6 -13% 34

EMD Serono 40 +4 11% Aspen 37 -6 -14% 3

Genentech 56 +3 6% Mylan 60 -5 -8% 28

Regeneron Pharmaceuticals 53 +3 6% Valeant 63 -4 -6% 390

Astellas 49 +3 7% Gilead Sciences 60 -4 -6% 365

Grifols 43 +3 8% GlaxoSmithKline 70 -3 -4% 466

Actelion 41 +3 8% Amgen 67 -3 -4% 490

Mitsubishi Tanabe Pharma 38 +3 9% Kite Pharma 48 -3 -6% 594

Shionogi 33 +3 10% Endo 43 -3 -7% 451

AstraZeneca 73 +2 3% Otsuka Pharmaceutical 39 -3 -7% 122

Roche 69 +2 3% Servier Laboratories 38 -3 -7% 148

Eli Lilly 68 +2 3% Pfizer 80 -2 -2% 1,218

Boehringer Ingelheim 61 +2 3% Novartis 73 -2 -3% 1,000

Eisai 39 +2 5% Teva 68 -2 -3% 413

*Ranked by Prior Month % Change

Science Trends

Groups

5

553

330

409

312

2

207

141

104

162

96

128

147

● New High (Media Rating)Mentions

(100)

115

98

878

161

184

892

383

RatingChg.

RatingChg.

© 2016 mediaQuant, Inc., All rights reserved. | [email protected]

……………………………………………………

License our Content

For reprint permission for this report or its data elements, please contact Mary Senatori. To order full versions of this report in online or

printed format, please visit www.mediaquant.net.

How to Read a Report……………………………………………………i,ii

Methodology……………………………………………………

84 ▲ + 1 Johnson and Johnson……………………………………………………3 36 ▼ - 11 Juno Therapeutics……………………………………………………103

80 ▼ - 2 Pfizer……………………………………………………5 35 ▲ + 2 Menarini……………………………………………………105

74 ▼ - 1 Sanofi……………………………………………………7 33 ▲ + 1 Kyowa Hakko Kirin……………………………………………………107

73 ▲ + 2 AstraZeneca……………………………………………………9 33 ▲ + 3 Shionogi……………………………………………………109

73 ▼ - 2 Novartis……………………………………………………11 27 – – Dainippon Sumitomo……………………………………………………111

70 ▼ - 6 Bayer HealthCare……………………………………………………13 27 ▲ + 1 Stallergenes……………………………………………………113

70 ▲ + 6 Bristol-Myers Squibb……………………………………………………15 27 – – Warner Chilcott……………………………………………………115

70 ▼ - 3 GlaxoSmithKline……………………………………………………17 26 ▼ - 1 NovoBiotic Pharmaceuticals……………………………………………………117

69 ▲ + 2 Roche……………………………………………………19

68 ▼ - 6 Allergan……………………………………………………21

68 ▲ + 2 Eli Lilly……………………………………………………23

68 ▼ - 2 Teva……………………………………………………25

67 ▼ - 3 Amgen……………………………………………………27

67 ▼ - 1 Novo Nordisk……………………………………………………29

64 ▲ + 1 Janssen Pharmaceuticals……………………………………………………31

63 ▲ + 4 Baxter International……………………………………………………33

63 ▼ - 4 Valeant……………………………………………………35

62 – – Abbott……………………………………………………37

62 ▼ - 2 Biogen Idec……………………………………………………39

61 ▲ + 2 Boehringer Ingelheim……………………………………………………41

61 ▲ + 1 Merck & Co.……………………………………………………43

60 ▲ + 4 Celgene……………………………………………………45

60 ▼ - 4 Gilead Sciences……………………………………………………47

60 ▼ - 5 Mylan……………………………………………………49

57 ▲ + 5 Actavis……………………………………………………51

56 ▲ + 3 Genentech……………………………………………………53

53 ▲ + 3 Regeneron Pharmaceuticals……………………………………………………55

52 ▼ - 7 Takeda……………………………………………………57

50 ▼ - 2 Shire……………………………………………………59

49 ▲ + 3 Astellas……………………………………………………61

49 ▲ + 5 Daiichi Sankyo……………………………………………………63

49 ▲ + 10 Hospira……………………………………………………65

48 ▼ - 3 Kite Pharma……………………………………………………67

48 ▲ + 1 Merck KGaA……………………………………………………69

48 ▼ - 1 UCB……………………………………………………71

45 ▲ + 7 CSL Limited……………………………………………………73

43 ▼ - 3 Endo……………………………………………………75

43 ▲ + 3 Grifols……………………………………………………77

42 ▼ - 9 Forest Laboratories……………………………………………………79

42 ▼ - 6 Purdue Pharma……………………………………………………81

41 ▲ + 3 Actelion……………………………………………………83

41 ▼ - 1 Galderma……………………………………………………85

41 ▼ - 6 Lundbeck……………………………………………………87

40 ▲ + 4 EMD Serono……………………………………………………89

39 ▲ + 2 Eisai……………………………………………………91

39 – – Elan……………………………………………………93

39 ▼ - 3 Otsuka Pharmaceutical……………………………………………………95

38 ▲ + 3 Mitsubishi Tanabe Pharma……………………………………………………97

38 ▼ - 3 Servier Laboratories……………………………………………………99

37 ▼ - 6 Aspen……………………………………………………101

52 ▼ - 1 1Pharmaceutical Brands118 - 119


PageSection and Summary Metrics* Section and Summary Metrics* Page

Table of Contents

How to Read a Report

Report Layout - Each premium report includes a 2-page summary of the trend, brand or influencer reports on each sector member (e.g., Chanel). We use the

Sector Report Two-page summary showing the topline media rating and featured segment-level ratings for the sector at large, and relative rank positions for the top-15 sector members.

Sector Report Sections

Page 2

� Peer Group Growth Comparison - Who’s leading, gainrelative to their peers? This chart shows the short(12-month) topline media rating growth for each member within the quadrant a member falls in is determined by its position against theaverage, i.e., below or above the sector average for shortand long-term (vertical axis) growth respectively.

� Geographic Performance - Shows segment-level across 3 key media regions: North America, Europe and Asia Pacific. Member reports show more granular geographic signal performance.

� Key-Segment Metrics and Rankings - Here we highlight segmentratings for the sector as well as rank positions within four key media segments: Global Print, Search Volume, Social Media and Online News

movements are highlighted in green and red.

How to Read a Report page summary of the trend, brand or influencer sector (e.g., Luxury Brands),

We use the Luxury Brands sector as an example.

media rating and featured and relative rank positions

Member Reports

Supporting two-page reports detailing topline and segmentrankings, and growth dynamics for each sector member. 60+ members, with new members added each month

� Box Scores - Here's where you get a snapshot of overall media prominence for the trend, brand or influencer sector, including: - topline media rating for the month encircled in large font, - topline media rating growth metrics: prior month and year - topline media rating average metrics: trailing 12-months and year

� Editorial Highlights - Provides commentary on noteworthy over prior periods.

�

Position - Illustrates the range of topline media ratings within the weak-to-strong 100-point scale, showing the high and low member endpoints (in gold) relative to the sector average (in black).

� Historical Performance - Shows the monthly movement and aggregate growth and decline of the sector topline media rating over the prior 4 yearsfor the time-period is denoted in green and red, respectively.

�

�

Peer Group Rankings and Highs/Lows - Our Billboard™ Magazinesector members, showing current rank and movement from the prior month/year. Any member showing a significant increase or decrease in rank position green or red respectively, where “significant” is 10% or more of the total number of sector members. Next to the ranking is a snapshot of the member’s currentmedia rating within the high-low spread for the trailing 12or low for the 12-month period is highlighted in green or red, respectively.handle ties according to the standard competition "1224" ranking method.)

Member Performance Thumbnails - A condensed toplinethe top 15 sector members, a trailing 12-month performance chart, change from prior month, year and YTD averages.

Who’s leading, gaining, falling and lagging relative to their peers? This chart shows the short-term (30-day) versus long-term

growth for each member within the sector. Which quadrant a member falls in is determined by its position against the sector

average for short-term (horizontal axis) term (vertical axis) growth respectively.

level media ratings for the sector across 3 key media regions: North America, Europe and Asia Pacific. Member reports show more granular geographic signal performance.

we highlight segment-level media as well as rank positions within four key media segments: All

Online News. Significant rank

All reports

include a 2-page

sector-level

summary plus

detailed

2-page sector

member reports.

(e.g., Luxury Brands), plus 2-page detail

topline and segment-level media ratings, member. Sectors may have

bers added each month.

Here's where you get a snapshot of overall media prominence for the

for the month encircled in large font, growth metrics: prior month and year-over-year, and

months and year-to-date.

s commentary on noteworthy media rating movement

s within the sector along a point scale, showing the high and low member endpoints (in

Shows the monthly movement and aggregate growth and over the prior 4 years. All-time high and low

period is denoted in green and red, respectively.

rd™ Magazine-like ranking of members, showing current rank and movement from the prior month/year. Any

showing a significant increase or decrease in rank position is highlighted in red respectively, where “significant” is 10% or more of the total number of

the member’s current-month low spread for the trailing 12-month period. A new high

month period is highlighted in green or red, respectively. (Note we handle ties according to the standard competition "1224" ranking method.)

topline media rating summary of month performance chart, change from prior

� Box Scores - Here's where you get a snapshot of overall media prominence for the sector member, including:

Topline media rating metrics: - topline media rating for the month encircled in large font,- topline media rating growth metrics: prior month and year- topline media rating average metrics: trailing 12-months and yeardate.

Sentiment: Shows what percentage of media rating (green) vs. negative (red).

Advertising Value Equivalent: Shows AVE for the current month and year-to-date (for brands only).

� Position - Shows member topline media rating (in gold) relative to average (in black) along a weak-to-strong 100-point scale.

� Historical Performance - Shows the monthly movement and aggregate growth and decline of the sector member topline media ratingAll-time high and low for the time-period is denoted in green and red, respectively.

� Core Segment Metrics - Shows the fifteen (15) segmentratings that comprise the topline media rating, along with their growth metrics.

� Expanded Segment Metrics - Shows 20+ segment-level along with their growth metrics to provide additional context and granularity.

Page 2

For further information on report terms and methodology, see For further information on report benefits, see our Benefits guide at

How To Read a Report. Copyright © 2015 mediaQuant, Inc. All rights reserved.

Member Report Here's where you get a snapshot of overall media

for the month encircled in large font, growth metrics: prior month and year-over-year,

months and year-to-

was positive

: Shows AVE for the current month and

(in gold) relative to sector point scale.

Shows the monthly movement and aggregate media rating over time.

period is denoted in green and red,

) segment-level media with their growth

level media ratings along with their growth metrics to provide additional context and

� Peer Group Growth Comparison - Who’s leading, gainlagging relative to their peers? This chart shows the shortversus long-term (12-month) topline media rating growth metrics for each member in the sector. Which quadrant a member falls in is determined by its position against the sector average, i.e., below or above the for short-term (horizontal axis) and long-term (vertical axis) growth respectively.

� Key Segment Highlights - While all 20+ media segments are highlighted on page 1, we break out six key segments to help graphically illustrate trending activity.

� Peer Group Ranking Breakout - Rank comparisons are provided in ascending order for each sector member's topline media ratinghighlighted in yellow). Detail includes prior month and prior year rank and prior month rank change. Current topline media rating and growth metrics are provided along with a trailing 12-month chart, with high and low ratings denoted in green and red respectively. (Note we handle ties according to the standard competition "1224" ranking method.)

For further information on report terms and methodology, see http://www.mediaquant.net/about/methodology/. For further information on report benefits, see our Benefits guide at http://www.mediaquant.net/downloads/pdfs/mediaQuant-benefits.pdf

. All rights reserved.

Member Report Sections

ing, falling and lagging relative to their peers? This chart shows the short-term (30-day)

growth metrics for each . Which quadrant a member falls in is determined by its

average, i.e., below or above the sector average term (vertical axis) growth

0+ media segments are highlighted segments to help graphically illustrate

Rank comparisons are provided in media rating (member

highlighted in yellow). Detail includes prior month and prior year rank and and growth metrics

month chart, with high and low media (Note we handle ties

according to the standard competition "1224" ranking method.)

Brands

Pharmaceutical Brands Brands

Prior Mo. Pt. Chg.

Prior Yr. Pt. Chg.

Trailing 12-Mo Avg

YTD Avg. Rating

Pharmaceutical Brands- 1

- 4

54

5352

�

��

For the Pharmaceutical Brands sector (comprising 58 brands), the topline media rating for

November 2016 is 52, a -1 change over the prior month and a -4 change over the prior year. The

media rating maximum and minimum within the sector are held by Johnson and Johnson (84) and

NovoBiotic Pharmaceuticals (26) respectively. The trailing 12-month average is 54, while the

current YTD average is 53. For regional media rating metrics (and prior month change): North

America reports 63 (-0 pts.) compared to Europe's 68 (+0 pts.) and Asia Pacific's 68 (-1 pts.).

Topline Media Rating

Sector topline media rating from October, 2012 through October, 2016

Johnson and Pfizer Sanofi

�

Trailing 12-month

Topline Media Rating Charts

NovartisAstraZeneca

� Low 52

Current Month Sector Rankings

Rank* Topline Media Rating

Top-15 Media Rating

High 6042

47

52

57

622012 2013 2014 2015 2016

26

Sector Average52

MaxMin 84 Extreme

(100)Weak...(0)

Moderate... Strong...

Low Close High

Johnson and Johnson 78 91

Pfizer 80 90

Sanofi 70 76

AstraZeneca 71 81 �Mo. �Mo. �Mo. �Mo. �Mo.

Novartis 73 81

Bayer HealthCare 62 78 12-Mo. Avg. 87 12-Mo. Avg. 84 12-Mo. Avg. 74 12-Mo. Avg. 74 12-Mo. Avg. 77

Bristol-Myers Squibb 61 70 89 83 73 73 77

GlaxoSmithKline 70 76

Roche 67 80

Allergan 68 79

Eli Lilly 63 73

Teva 64 74

Amgen 66 75

Novo Nordisk 55 68

Janssen Pharmaceuticals 59 66

Baxter International 59 72 �Mo. �Mo. �Mo. �Mo. �Mo.

Valeant 63 85

Abbott 59 75 12-Mo. Avg. 70 12-Mo. Avg. 65 12-Mo. Avg. 72 12-Mo. Avg. 70 12-Mo. Avg. 73

Biogen Idec 58 70 70 65 72 70 73

Boehringer Ingelheim 54 62

Merck & Co. 58 82

Celgene 56 68

Gilead Sciences 60 69

Mylan 51 66

Actavis 52 67

Genentech 51 59

Regeneron Pharmaceuticals 46 57

Takeda 50 60 �Mo. �Mo. �Mo. �Mo. �Mo.

Shire 50 63

Astellas 46 57 12-Mo. Avg. 69 12-Mo. Avg. 69 12-Mo. Avg. 70 12-Mo. Avg. 62 12-Mo. Avg. 63

Cur

rent

Cha

nge

Johnson and

Johnson

Pfizer Sanofi

1 84

Novartis

73 73

AstraZeneca Rank* Topline Media Rating

3

80

70

+2

70 69

-5

18

- 12

13

YTD Avg.YTD Avg.

26 -

30 +7 49

29

68

�Yr. �Yr. �Yr.

-6

�Yr.�Yr.

-2

-3

-1

+1

Teva

- 7�Yr.

-8

-6

Amgen Novo Nordisk Janssen

Pharmaceuticals

67 67 64

�Yr.+ 7 + 7

-3

- 10 �Yr.

+1-1

10

YTD Avg.

9 +3 69 Bayer

HealthCare

6 +1 70

62

16 -4 63

74 84

Bristol-Myers

Squibb

70

-4 68

6

+1 74

�Yr.

-3 70

62

18 -2

+2

2

Roche

-4 67

-1

+4 68

68 70

-1

-2 67

+4 64

-2

AllerganGlaxoSmithKline

�Yr.

+2

YTD Avg.

60

+2

+1

+6

�Yr.

+ - 8

YTD Avg.

�Yr.

YTD Avg. YTD Avg.

61

YTD Avg.

+ 4

+1

- 8 �Yr. - 4

-

-2

4

4

- 73

80

-

�Yr.

+4

�Yr.

12-Month

Rating Range

73

50-2

6 +10

16

10

10

-7

63

+2 57

22

+4

20 61

22 -6 60

+2

13

15

+6

■ / ■ Trending Up/Down

68

Eli Lilly

22 +3 60

YTD Avg.

- 10

20

56

68

YTD Avg.

28 -6 52

27 53

25

Astellas 46 57 12-Mo. Avg. 69 12-Mo. Avg. 69 12-Mo. Avg. 70 12-Mo. Avg. 62 12-Mo. Avg. 63

Daiichi Sankyo 42 49 69 69 70 61 62+9 YTD Avg.30 49

30 +7 49

YTD Avg.YTD Avg. YTD Avg. YTD Avg.

1 © 2016 mediaQuant, All rights reserved.| [email protected] *A positive or negative rank change of +/- 6 positions or greater is highlighted in green or red.

North America

-0

66

+0

70

-1

Regional Media Rating

Coverage Distribution (%)

2016NOVEMBER

68

68

63 Europe

Asia

Pt. Chg.

YTD Avg.

Pt. Chg.

YTD Avg.

Pt. Chg.


Pharmaceutical Brands Short (30 day) vs. Long Term (12-mo.) Comparison

55%

28%

17%

Gai

nin

g M

om

entu

mL

on

g (1

2-M

onth

)Med

ia R

atin

g

Gro

wth

Johnson and Johnson

Pfizer

Sanofi

AstraZeneca

NovartisBayer HealthCare

Bristol-Myers Squibb

GlaxoSmithKline

Roche

Allergan

Category Avg: -1

Category Avg: -1

Category Avg: -1 Category Avg: -1

Eli Lilly

Teva

Amgen

Novo NordiskJanssen

Pharmaceuticals

Baxter International

Valeant

Abbott

Biogen Idec

Boehringer Ingelheim

-26

-21

-16

-11

-6

-1

+4

+9

+14 LeadingFalling

Lagging Gaining-1

71

1 +1 1 +47 1 - 1 -

2 +1 2 -1 2 +4 2 +1

3 +5 3 -1 3 - 3 -1

4 +1 4 +2 4 +5 4 -

5 -2 5 -1 5 -3 5 -1

6 +5 6 -2 5 +4 6 +9

7 +9 7 +1 7 -3 7 +11

7 -1 8 +1 8 -4 8 -1

7 +7 9 -2 9 +8 8 -2

10 +2 9 +7 10 +1 10 +1

10 -2 11 +1 10 +1 10 -2

10 -9 12 -9 12 +2 12 +1

10 +6 12 +1 13 +2 13 -2

14 -4 14 -5 14 +1 13 +2

14 -8 15 -1 15 +14 15 -6

14 -1 16 -1 16 -9 16 -7

17 -1 17 +5 16 +1 16 +3

18 +1 18 +1 16 +9 18 -1

19 - 19 -3 19 +8 19 -5

19 +3 20 +4 19 +10 20 -

Merck KGaA

Prior Yr. Growth

Celgene Amgen EMD Serono Boehringer Ingelheim

Mylan Novartis Kite Pharma GlaxoSmithKline

Teva Novo Nordisk Sanofi Allergan

Valeant Grifols Boehringer Ingelheim Eli Lilly

Novo Nordisk AstraZeneca Daiichi Sankyo Grifols

Biogen Idec GlaxoSmithKline

Amgen

Abbott

Celgene

-0.2

Bayer HealthCare

+0

Sanofi Roche Pfizer Janssen Pharmaceuticals

Bristol-Myers Squibb Sanofi

Rank (Current | �Prior Mo.) Rank (Current | �Prior Mo.)Rank (Current | �Prior Mo.) Rank (Current | �Prior Mo.)

YTD Avg. Rating 40

Online News

Prior Yr. Growth -0.0 Prior Yr. Growth +0.1 Prior Yr. Growth

YTD Avg. Rating

Abbott Baxter International Novartis

Pfizer Mitsubishi Tanabe Pharma Johnson and Johnson

42

-0.2

Current

Month

-1 Prior Mo. Pt. Chg.

30 YTD Avg. Rating 41

Allergan

Bayer HealthCare

Eli Lilly

Novartis Baxter International Novo Nordisk

Global Print Search Volume Social Media

Amgen

Current

Month65Current

Month 42 30

YTD Avg. Rating

Current

Month

Prior Mo. Pt. Chg. -1 Prior Mo. Pt. Chg. +1 Prior Mo. Pt. Chg.

68

GlaxoSmithKline

Baxter International

Gilead SciencesMerck & Co.

Pfizer

UCB

Allergan

AstraZeneca

Novo Nordisk

Sanofi Teva

Amgen

Biogen Idec

Eli Lilly

Roche Elan Bayer HealthCare Valeant

Bristol-Myers Squibb Mylan Novartis

Johnson and Johnson

Johnson and Johnson


AstraZeneca

Bayer HealthCare Forest Laboratories

AstraZeneca Actavis Janssen Pharmaceuticals

Merck & Co.

TevaGlaxoSmithKline

Segment-Level Media Rating Metrics and Rankings

68Pt. Chg.

YTD Avg.

Pfizer

Gaining MomentumShort (30-day) Media Rating GrowthLosingMomentum

Category Avg: -1-26

-13 -8 -3 +2 +7

Gaining

19 +3 20 +4 19 +10 20 -Celgene Amgen EMD Serono Boehringer Ingelheim

© 2016 mediaQuant, All rights reserved. | [email protected] 2A positive or negative rank change of +/- 6 positions or greater is highlighted in green or red.

Sentiment Breakout

Johnson and Johnson's topline media rating for November 2016 is 84, a +1 change

over the prior month value of 83 and a moderate +4 change over the prior-year media

rating of 80. This compares favorably to the Pharmaceutical Brands sector media rating

average of 52. Johnson and Johnson's media rating max and min for the trailing 12-

month period are 91 in October 2016 and 78 in November 2015.

Advertising Value: Johnson and Johnson's media rating of 84 translates into a current

month AVE of $52,577,343, with a trailing 12-month total of $2,896,553,293.

Ranking: Within the Pharmaceutical Brands sector, Johnson and Johnson is currently

ranked no.1, showing no measurable rank change over the prior month. Year-over-year,

Johnson and Johnson experienced a moderate gain of +4 in the Sector ranking.

Growth Quadrant: For the November 2016 reporting period, Johnson and Johnson is in

the Leading quadrant vis-à-vis its peers, showing a +1 change in short term (prior

month) growth and a moderate +4 change in long term (prior year) growth, versus the

sector average.

+1

87

89YTD Avg. Rating

Trailing 12-Mo. Avg.

Prior Mo. Rating Chg.

Johnson and Johnson Brands

�

$52,577,343 $2,896,553,293Current Month AVE

Prior Yr. Rating Chg.

Advertising Value Equivalents

Trailing 12-Month AVE


84+4 �

90

1002012 2013 2014 2015 2016

100% 0%

84

Sector Average52

Johnson and Johnson

Extreme(100)

Weak...(0)


Trailing 4-year topline media rating through 2016 �� High 91 ��

90 86 77 85 21 98 96 - 98

88 87 73 78 15 98 97 - 97

90 88 75 76 76 74 65 - 76

Month Month

Low High Close Chg. Low Close High Close Chg.

Online Sources 68 95 +1 81 90 87 +2

72 98 +1 - 87 92 88 -

69 99 - # 78 89 85 +7

15 82 +6 # 70 80 77 +4

# 84 95 92 +2

61 98 -1 # 90 95 91 +1

67 99 - # 72 91 86 +3

70 98 +1

90 95 91 +1

- 98 99 99 -

86 92 -3 # 88 94 91 +3

85 90 -1 # 89 94 90 +1

83 89 -4 # 86 93 89 +3

83 97 -12 # 86 95 86 -3

87 92 +2 # 84 95 92 +2

Low 75

83 86

83

Prior Month

Prior Year

Editorial ProminenceRegional Prominence Online / Viral Prominence

99

Twitter

68

99

Top US

Papers

Search

Vol.

Top

Cons.

Topline

Media Rating

Segments

Global Web

Forums

1%

GroupsTop TradeWW

Papers

Top

Bus.

Global

Web

BlogsOnline

News

AsiaNorth

America

Europe

92 92

90 90 97

91

87 89

98

93 71

92 Current Month

#

-

#

Online News

48%

32%

21 -72%

86#

#

#

#

83

12-Month Rating Range

Asia

Twitter

Forums

Regional Print Metrics

-

#

Europe

# Blogs

Search Volume

#

0%

-7%

Top Business

Top Consumer

North America 90

-13%

0%

83South America

Segment-Level Media

Rating Metrics

YearYear 12-Month Rating RangeSegment-Level Media

Rating Metrics

3%

12%98

Close Chg.

Top Business

85

Chg.

18% Top Media Sources

Top Global Print

Top US Newspapers

WW Newspapers

98 38%

6%

-2%

0%

Top Healthcare

Top Industrial

Top Services

0%

0%

Top Technology -1%

-2%

96

99

98

0%

86 -3%

-2%

29%

Top Industry

46%

-2%

6%

Industry-Specific Media

Broadcast

60

70

80

87 92 +2 # 84 95 92 +2# 0%Top Business

3 © 2016 mediaQuant, All rights reserved. | [email protected]

North America 90 0%

�Yr.

�Mo

+38%

+0%

Short (30 day) vs. Long Term (12-mo.) Sector Comparison

Social Media

Global Web

NOVEMBER

2016

�Yr. +32%

�Yr. +40%

�Mo +0%

�Mo. +1%

Online News

Johnson and Johnson within the Pharmaceutical Brands SectorSegment-Level Media Rating Metrics

for Trailing 12-Months


98

98

Gai

nin

g M

om

entu

mL

on

g (1

2-M

onth

)Med

ia R

atin

g G

row

th

Johnson and Johnson

-26

-21

-16

-11

-6

-1

+4

+9

+14 LeadingFalling

Lagging Gaining

1 1 5 Johnson and Johnson -

2 2 1 Pfizer -

3 4 8 Sanofi +1

4 8 14 AstraZeneca +4

4 4 4 Novartis -

6 3 9 Bayer HealthCare -3

6 16 15 Bristol-Myers Squibb +10

6 7 13 GlaxoSmithKline +1

9 12 7 Roche +3

10 6 5 Allergan -4

10 14 11 Eli Lilly +4

10 9 17 Teva -1

13 9 9 Amgen -4

13 11 23 Novo Nordisk -2

15 19 26 Janssen Pharmaceuticals +4

16 22 20 Baxter International +6

16 12 2 Valeant -4

18 20 11 Abbott +2

18 16 15 Biogen Idec -2

1 84

84

-6%

+1

Johnson and Johnson +01 5

Cur

rent

+1

Current

Month

� Prior

Month YTD Global Print

-10%

73 -5%

83 -9%

89

12%

62

-27%

+6%

+29%

-72%

r Yr.

5%89

Prio

r M

o.

Prio

r Y

r.

Ran

k C

hg.

Pharmaceutical Brands Sector ►


Rank Comparisons

+062

63 +4 67

�Mo.

�Yr.70

12%

-15%-6 73

�Mo.

-13%

-2%

-13%

65

62 -2 63 -13%

+3%

�Yr.

5%

-18%

0%

-9%

-1%

-7%

1%

-11%

70

67

64 62

63 -4 74

70 -3 72

+1

61-1

-3 70

-2 69

+2 69

+2

68

70

68

�Mo +0%

�Yr. +1%

73 Search Volume

Broadcast

-2 77

69

68

+2 73

-6

70 +6

73

67

Growth

YOY

Trailing 12

Mo.

Topline Media Rating Metrics

74

52 -0 54

-1

80 -2

98

88

21

86

Gaining MomentumLosingMomentum Short (30-day) Media Raing Growth

-26

-13 -8 -3 +2 +7


20 22 24 Boehringer Ingelheim +2 58 3%+261

62 63

© 2016 mediaQuant, All rights reserved. | [email protected] 4

Sentiment Breakout

Pfizer's topline media rating for November 2016 is 80, a moderate -2 change over the

prior month value of 82 and a notable -8 change over the prior-year media rating of 88.

This compares favorably to the Pharmaceutical Brands sector media rating average of

52. Pfizer's media rating max and min for the trailing 12-month period are 90 in

November 2015 and 80 in March 2016.

Advertising Value: Pfizer's media rating of 80 translates into a current month AVE of

$1,284,171, with a trailing 12-month total of $28,587,201.

Ranking: Within the Pharmaceutical Brands sector, Pfizer is currently ranked no.2,

showing no measurable rank change over the prior month. Year-over-year, Pfizer

experienced a loss of -1 in the Sector ranking.

Growth Quadrant: For the November 2016 reporting period, Pfizer is in the Lagging

quadrant vis-à-vis its peers, showing a moderate -2 change in short term (prior month)

growth and a notable -8 change in long term (prior year) growth, versus the sector

average.

-2

84

83

YTD Avg. Rating



Pfizer Brands

�

$1,284,171 $28,587,201Current Month AVE





80-8 �

83

88

932012 2013 2014 2015 2016

83% 17%

80

Sector Average52

Pfizer

Extreme(100)

Weak...(0)



92 88 78 87 67 76 54 - 69

92 89 78 87 80 82 58 - 70

94 91 85 92 68 93 83 - 79

Month Month


Online Sources 67 82 -4 85 94 85 -1

68 89 -4 - 89 96 89 -

73 91 -6 - 84 97 87 -

67 80 -13 - 78 94 78 -

# 93 98 95 +1

51 88 -4 - 92 97 92 -

70 77 +1 # 88 95 89 +1

55 75 -1

92 97 92 -

- 99 100 99 -

90 96 -1 # 90 97 92 +2

88 96 -1 - 92 97 92 -

89 97 - # 85 95 85 -4

89 98 - # 86 97 87 +1

91 97 - # 93 98 95 +1

Low 79

89 87

93

Prior Month

Prior Year


71

Twitter

81

70

Top US

Papers

Search

Vol.

Top

Cons.

Topline

Media Rating

Segments

Global Web

Forums

-4%

GroupsTop TradeWW

Papers

Top

Bus.

Global

Web

BlogsOnline

News

AsiaNorth

America

Europe

94 96

94 92 73

92

89 86

69

95 90

95 Current Month

#

#

#

Online News

-35%

-18%

67 -1%

88#

-

-

-

89


Asia

Twitter

Forums


#

#

Europe

# Blogs

Search Volume

#

-1%

-7%

Top Business

Top Consumer

North America 92

-3%

-2%

93South America

Segment-Level Media

Rating Metrics


Rating Metrics

-8%

-5%76

Close Chg.

Top Business

68

Chg.

-17% Top Media Sources

Top Global Print

Top US Newspapers

WW Newspapers

69 -23%

-8%

-3%

-4%

Top Healthcare

Top Industrial

Top Services

-2%

0%

Top Technology -8%

-2%

54

71

69

-1%

90 -4%

-3%

-13%

Top Industry

-12%

-3%

-1%


Broadcast

63

68

73

78

83

91 97 - # 93 98 95 +1- -1%Top Business


North America 92 -2%

�Yr.

�Mo

-23%

-2%


Social Media

Global Web

NOVEMBER

2016

�Yr. -18%

�Yr. -20%

�Mo -8%

�Mo. -6%

Online News

Pfizer within the Pharmaceutical Brands SectorSegment-Level Media Rating Metrics



69

65

76

Gai

nin

g M

om

entu

mL

on

g (1

2-M

onth

)Med

ia R

atin

g G

row

th

Pfizer

-26

-21

-16

-11

-6

-1

+4

+9

+14 LeadingFalling

Lagging Gaining


2 2 1 Pfizer -

3 4 8 Sanofi +1


4 4 4 Novartis -




9 12 7 Roche +3

10 6 5 Allergan -4

10 14 11 Eli Lilly +4

10 9 17 Teva -1

13 9 9 Amgen -4




16 12 2 Valeant -4

18 20 11 Abbott +2


2 80

84

-6%

+1

Pfizer +02 1

Cur

rent

-2

Current

Month

� Prior


-10%

73 -5%

83 -9%

89

12%

62

-27%

-1%

-19%

-1%

r Yr.

-9%83

Prio

r M

o.

Prio

r Y

r.

Ran

k C

hg.



Rank Comparisons

+062

63 +4 67

�Mo.

�Yr.70

12%

-15%-6 73

�Mo.

-13%

-2%

-13%

65

62 -2 63 -13%

+1%

�Yr.

5%

-18%

0%

-9%

-1%

-7%

1%

-11%

70

67

64 62

63 -4 74

70 -3 72

+1

61-1

-3 70

-2 69

+2 69

+2

68

70

68

�Mo +0%

�Yr. -4%

73 Search Volume

Broadcast

-2 77

69

68

+2 73

-6

70 +6

73

67

Growth

YOY

Trailing 12

Mo.


74

52 -0 54

-1

80 -2

76

89

67

89


-26

-13 -8 -3 +2 +7



62 63


Sentiment Breakout

Sanofi's topline media rating for November 2016 is 74, a -1 change over the prior month

value of 75 and a moderate -4 change over the prior-year media rating of 78. This

compares favorably to the Pharmaceutical Brands sector media rating average of 52.

Sanofi's media rating max and min for the trailing 12-month period are 78 in October

2016 and 70 in November 2015.

Advertising Value: Sanofi's media rating of 74 translates into a current month AVE of

$884,537, with a trailing 12-month total of $10,568,340.

Ranking: Within the Pharmaceutical Brands sector, Sanofi is currently ranked no.3,

showing a negligible +1 rank change over the prior month. Year-over-year, Sanofi

experienced a notable gain of +5 in the Sector ranking.

Growth Quadrant: For the November 2016 reporting period, Sanofi is in the Falling

quadrant vis-à-vis its peers, showing a -1 change in short term (prior month) growth

and a moderate -4 change in long term (prior year) growth, versus the sector average.

-1

74

73YTD Avg. Rating



Sanofi Brands

�

$884,537 $10,568,340Current Month AVE





74-4 �

76

81

862012 2013 2014 2015 2016

80% 20%

74

Sector Average52

Sanofi

Extreme(100)

Weak...(0)



86 86 66 77 69 75 38 - 52

89 89 69 83 56 72 37 - 54

85 88 65 75 60 83 67 - 64

Month Month


Online Sources 53 59 +2 73 83 80 -3

58 72 -3 # 83 88 84 -4

6 75 +3 # 69 87 77 -6

54 69 +13 # 65 77 66 -3

# 92 96 93 -3

28 66 +1 # 87 93 88 -5

55 73 +1 # 84 92 84 -5

36 63 -2

87 93 88 -5

- 99 (equal) 99 99 -

88 93 -4 # 83 92 86 -5

84 92 -3 # 85 94 85 -6

88 93 -2 # 74 89 78 -11

87 98 -5 # 81 90 84 -6

85 91 -3 # 92 96 93 -3

Low 70

91 84

89

Prior Month

Prior Year


60

Twitter

74

59

Top US

Papers

Search

Vol.

Top

Cons.

Topline

Media Rating

Segments

Global Web

Forums

0%

GroupsTop TradeWW

Papers

Top

Bus.

Global

Web

BlogsOnline

News

AsiaNorth

America

Europe

81 92

96 93 64

88

93 90

61

88 73

93 Current Month

#

#

#

Online News

-43%

-10%

69 15%

86#

#

#

#

91


Asia

Twitter

Forums


#

#

Europe

# Blogs

Search Volume

#

1%

4%

Top Business

Top Consumer

North America 86

17%

1%

91South America

Segment-Level Media

Rating Metrics


Rating Metrics

2%

3%75

Close Chg.

Top Business

59

Chg.


Top Global Print

Top US Newspapers

WW Newspapers

61 -16%

-1%

-2%

2%

Top Healthcare

Top Industrial

Top Services

-2%

0%

Top Technology -3%

-1%

38

60

52

1%

88 4%

0%

-19%

Top Industry

-19%

0%

-7%


Broadcast

56

61

66

71

76

85 91 -3 # 92 96 93 -3# 1%Top Business


North America 86 1%

�Yr.

�Mo

-16%

+0%


Social Media

Global Web

NOVEMBER

2016

�Yr. -10%

�Yr. -26%

�Mo +4%

�Mo. -5%

Online News

Sanofi within the Pharmaceutical Brands SectorSegment-Level Media Rating Metrics



61

50

75

Gai

nin

g M

om

entu

mL

on

g (1

2-M

onth

)Med

ia R

atin

g G

row

th

Sanofi

-26

-21

-16

-11

-6

-1

+4

+9

+14 LeadingFalling

Lagging Gaining


2 2 1 Pfizer -

3 4 8 Sanofi +1


4 4 4 Novartis -




9 12 7 Roche +3

10 6 5 Allergan -4

10 14 11 Eli Lilly +4

10 9 17 Teva -1

13 9 9 Amgen -4




16 12 2 Valeant -4

18 20 11 Abbott +2


3 74

84

-6%

+1

Sanofi +14 8

Cur

rent

-1

Current

Month

� Prior


-10%

73 -5%

83 -9%

89

12%

62

-27%

-7%

+19%

+15%

r Yr.

-5%73

Prio

r M

o.

Prio

r Y

r.

Ran

k C

hg.



Rank Comparisons

+062

63 +4 67

�Mo.

�Yr.70

12%

-15%-6 73

�Mo.

-13%

-2%

-13%

65

62 -2 63 -13%

-6%

�Yr.

5%

-18%

0%

-9%

-1%

-7%

1%

-11%

70

67

64 62

63 -4 74

70 -3 72

+1

61-1

-3 70

-2 69

+2 69

+2

68

70

68

�Mo -5%

�Yr. +0%

73 Search Volume

Broadcast

-2 77

69

68

+2 73

-6

70 +6

73

67

Growth

YOY

Trailing 12

Mo.


74

52 -0 54

-1

80 -2

75

84

69

84


-26

-13 -8 -3 +2 +7



62 63


84

Sentiment Breakout

AstraZeneca's topline media rating for November 2016 is 73, a moderate +2 change over

the prior month value of 71 and no measurable change over the prior-year media rating

of 73. This compares favorably to the Pharmaceutical Brands sector media rating

average of 52. AstraZeneca's media rating max and min for the trailing 12-month period

are 81 in October 2016 and 71 in October 2015.

Advertising Value: AstraZeneca's media rating of 73 translates into a current month AVE

of $582,963, with a trailing 12-month total of $10,368,722.

Ranking: Within the Pharmaceutical Brands sector, AstraZeneca is currently ranked

no.4, showing a moderate +4 rank change over the prior month. Year-over-year,

AstraZeneca experienced a large gain of +10 in the Sector ranking.

Growth Quadrant: For the November 2016 reporting period, AstraZeneca is in the

Leading quadrant vis-à-vis its peers, showing a moderate +2 change in short term (prior

month) growth and no measurable long term (prior year) growth, versus the sector

average.

+2

74

73YTD Avg. Rating



AstraZeneca Brands

�






73+0 �

76

81

862012 2013 2014 2015 2016

100% 0%

73

Sector Average52

AstraZeneca

Extreme(100)

Weak...(0)



87 84 79 78 53 67 41 - 52

82 85 83 69 52 66 38 - 53

83 82 71 59 62 67 58 - 55

Month Month


Online Sources 49 64 +1 79 88 81 +1

46 64 -3 # 83 91 86 +2

60 73 +1 # 63 87 78 +9

51 62 +1 # 77 86 79 -4

# 90 97 94 +4

28 63 +3 # 84 95 91 +1

47 69 +6 # 79 92 81 -2

34 57 -1

84 95 91 +1

# 98 99 99 +1

82 92 +5 - 89 94 89 -

84 91 -1 # 32 94 89 +1

89 95 +3 # 89 94 89 -1

74 97 +11 # 87 95 87 -1

82 92 +5 # 90 97 94 +4

Low 71

92 87

90

Prior Month

Prior Year


53

Twitter

66

47

Top US

Papers

Search

Vol.

Top

Cons.

Topline

Media Rating

Segments

Global Web

Forums

5%

GroupsTop TradeWW

Papers

Top

Bus.

Global

Web

BlogsOnline

News

AsiaNorth

America

Europe

87 91

90 90 53

91

89 88

50

89 62

94 Current Month

#

#

#

Online News

-29%

0%

53 -15%

84#

#

#

#

92


Asia

Twitter

Forums


#

#

Europe

# Blogs

Search Volume

#

3%

0%

Top Business

Top Consumer

North America 87

13%

5%

85South America

Segment-Level Media

Rating Metrics


Rating Metrics

11%

32%67

Close Chg.

Top Business

53

Chg.


Top Global Print

Top US Newspapers

WW Newspapers

50 -19%

7%

2%

2%

Top Healthcare

Top Industrial

Top Services

1%

1%

Top Technology 5%

3%

41

53

52

3%

87 6%

2%

-5%

Top Industry

-20%

2%

0%


Broadcast

56

61

66

71

76

82 92 +5 # 90 97 94 +4# 3%Top Business


North America 87 5%

�Yr.

�Mo

-19%

+6%


Social Media

Global Web

NOVEMBER

2016

�Yr. +0%

�Yr. -18%

�Mo +1%

�Mo. -6%

Online News

AstraZeneca within the Pharmaceutical Brands SectorSegment-Level Media Rating Metrics



50

49

67

Gai

nin

g M

om

entu

mL

on

g (1

2-M

onth

)Med

ia R

atin

g G

row

th

AstraZeneca

-26

-21

-16

-11

-6

-1

+4

+9

+14 LeadingFalling

Lagging Gaining


2 2 1 Pfizer -

3 4 8 Sanofi +1


4 4 4 Novartis -




9 12 7 Roche +3

10 6 5 Allergan -4

10 14 11 Eli Lilly +4

10 9 17 Teva -1

13 9 9 Amgen -4




16 12 2 Valeant -4

18 20 11 Abbott +2


4 73

84

-6%

+1

AstraZeneca +48 14

Cur

rent

+2

Current

Month

� Prior


-10%

73 -5%

83 -9%

89

12%

62

-27%

+0%

+2%

-15%

r Yr.

0%73

Prio

r M

o.

Prio

r Y

r.

Ran

k C

hg.



Rank Comparisons

+062

63 +4 67

�Mo.

�Yr.70

12%

-15%-6 73

�Mo.

-13%

-2%

-13%

65

62 -2 63 -13%

-2%

�Yr.

5%

-18%

0%

-9%

-1%

-7%

1%

-11%

70

67

64 62

63 -4 74

70 -3 72

+1

61-1

-3 70

-2 69

+2 69

+2

68

70

68

�Mo +2%

�Yr. +5%

73 Search Volume

Broadcast

-2 77

69

68

+2 73

-6

70 +6

73

67

Growth

YOY

Trailing 12

Mo.


74

52 -0 54

-1

80 -2

67

86

53

81


-26

-13 -8 -3 +2 +7



62 63


Sentiment Breakout

Novartis' topline media rating for November 2016 is 73, a moderate -2 change over the



52. Novartis' media rating max and min for the trailing 12-month period are 81 in August

2016 and 73 in April 2016.

Advertising Value: Novartis' media rating of 73 translates into a current month AVE of

$1,008,794, with a trailing 12-month total of $16,490,927.

Ranking: Within the Pharmaceutical Brands sector, Novartis is currently ranked no.4,

showing no measurable rank change over the prior month. Year-over-year, Novartis

experienced no change in the Sector ranking.

Growth Quadrant: For the November 2016 reporting period, Novartis are in the Lagging



average.

-2

77

77YTD Avg. Rating



Novartis Brands

�

$1,008,794 $16,490,927Current Month AVE





73-8 �

88

982012 2013 2014 2015 2016

89% 11%

73

Sector Average52

Novartis

Extreme(100)

Weak...(0)



85 86 61 68 65 80 45 - 59

86 89 74 67 62 81 42 - 57

89 89 74 81 67 85 67 - 64

Month Month


Online Sources 58 72 - 76 86 76 -6

61 80 -2 # 82 90 82 -3

76 87 -1 # 67 84 68 +1

59 75 +3 # 61 76 61 -13

- 92 96 92 -

31 77 +3 # 85 94 85 -3

56 77 -4 # 82 91 87 -4

39 64 +2

85 94 85 -3

- 99 (equal) 99 99 -

84 94 -4 # 86 94 86 -1

86 93 -3 # 84 93 84 -3

90 94 -1 # 79 92 80 +1

75 97 -13 # 68 93 68 -17

85 92 -1 - 92 96 92 -

Low 73

90 68

92

Prior Month

Prior Year


60

Twitter

76

64

Top US

Papers

Search

Vol.

Top

Cons.

Topline

Media Rating

Segments

Global Web

Forums

-7%

GroupsTop TradeWW

Papers

Top

Bus.

Global

Web

BlogsOnline

News

AsiaNorth

America

Europe

86 94

92 88 63

85

91 85

61

91 81

92 Current Month

#

#

#

Online News

-33%

-6%

65 -3%

86#

#

#

#

90


Asia

Twitter

Forums


#

#

Europe

# Blogs

Search Volume

#

-2%

-21%

Top Business

Top Consumer

North America 85

-20%

-4%

75South America

Segment-Level Media

Rating Metrics


Rating Metrics

-18%

-16%80

Close Chg.

Top Business

62

Chg.


Top Global Print

Top US Newspapers

WW Newspapers

61 -25%

-11%

-3%

-2%

Top Healthcare

Top Industrial

Top Services

-4%

0%

Top Technology -6%

-7%

45

60

59

-2%

84 -8%

-7%

-8%

Top Industry

-21%

-7%

-2%


Broadcast

58

68

78

85 92 -1 - 92 96 92 -# -2%Top Business



�Yr.

�Mo

-25%

+2%


Social Media

Global Web

NOVEMBER

2016

�Yr. -6%

�Yr. -20%

�Mo -1%

�Mo. -3%

Online News

Novartis within the Pharmaceutical Brands SectorSegment-Level Media Rating Metrics



61

55

Gai

nin

g M

om

entu

mL

on

g (1

2-M

onth

)Med

ia R

atin

g G

row

th

Novartis

-26

-21

-16

-11

-6

-1

+4

+9

+14 LeadingFalling

Lagging Gaining


2 2 1 Pfizer -

3 4 8 Sanofi +1


4 4 4 Novartis -




9 12 7 Roche +3

10 6 5 Allergan -4

10 14 11 Eli Lilly +4

10 9 17 Teva -1

13 9 9 Amgen -4




16 12 2 Valeant -4

18 20 11 Abbott +2


4 73

84

-6%

+1

Novartis +04 4

Cur

rent

-2

Current

Month

� Prior


-10%

73 -5%

83 -9%

89

12%

62

-27%

-2%

+5%

-3%

r Yr.

-10%77

Prio

r M

o.

Prio

r Y

r.

Ran

k C

hg.



Rank Comparisons

+062

63 +4 67

�Mo.

�Yr.70

12%

-15%-6 73

�Mo.

-13%

-2%

-13%

65

62 -2 63 -13%

-5%

�Yr.

5%

-18%

0%

-9%

-1%

-7%

1%

-11%

70

67

64 62

63 -4 74

70 -3 72

+1

61-1

-3 70

-2 69

+2 69

+2

68

70

68

�Mo -4%

�Yr. -7%

73 Search Volume

Broadcast

-2 77

69

68

+2 73

-6

70 +6

73

67

Growth

YOY

Trailing 12

Mo.


74

52 -0 54

-1

80 -2

80

82

65

87


-26

-13 -8 -3 +2 +7



62 63


Sentiment Breakout

Bayer HealthCare's topline media rating for November 2016 is 70, a notable -6 change

over the prior month value of 76 and a notable -7 change over the prior-year media


average of 52. Bayer HealthCare's media rating max and min for the trailing 12-month

period are 78 in September 2016 and 62 in January 2016.

Advertising Value: Bayer HealthCare's media rating of 70 translates into a current month

AVE of $496,038, with a trailing 12-month total of $16,598,947.

Ranking: Within the Pharmaceutical Brands sector, Bayer HealthCare is currently ranked

no.6, showing a moderate -3 rank change over the prior month. Year-over-year, Bayer

HealthCare experienced a moderate gain of +3 in the Sector ranking.

Growth Quadrant: For the November 2016 reporting period, Bayer HealthCare is in the

Lagging quadrant vis-à-vis its peers, showing a notable -6 change in short term (prior

month) growth and a notable -7 change in long term (prior year) growth, versus the

sector average.

-6

70

70YTD Avg. Rating



Bayer HealthCare Brands

�






70-7 �

79

892012 2013 2014 2015 2016

100% 0%

70

Sector Average52

Bayer HealthCare

Extreme(100)

Weak...(0)



79 84 69 70 76 53 43 - 64

91 89 83 87 79 61 44 - 49

80 85 62 72 80 94 64 - 60

Month Month


Online Sources 46 72 -1 64 85 74 -11

45 71 -5 # 76 91 81 -9

49 96 -8 # 44 87 70 -17

69 84 -3 # 49 83 69 -14

# 73 96 87 -9

21 60 -1 # 86 96 87 -7

32 69 -2 # 81 95 81 -12

27 64 +15

86 96 87 -7

# 97 99 98 -1

82 93 -8 # 87 97 91 -4

82 91 -5 # 81 97 90 -7

79 94 -6 # 75 92 75 -11

75 97 -13 # 82 93 82 -9

74 92 -12 # 73 96 87 -9

Low 62

88 82

85

Prior Month

Prior Year


35

Twitter

67

37

Top US

Papers

Search

Vol.

Top

Cons.

Topline

Media Rating

Segments

Global Web

Forums

-5%

GroupsTop TradeWW

Papers

Top

Bus.

Global

Web

BlogsOnline

News

AsiaNorth

America

Europe

86 86

96 94 51

87

94 91

46

89 72

87 Current Month

#

#

#

Online News

-33%

-44%

76 -5%

84#

#

#

#

88


Asia

Twitter

Forums


#

#

Europe

# Blogs

Search Volume

#

1%

-5%

Top Business

Top Consumer

North America 79

-10%

-1%

83South America

Segment-Level Media

Rating Metrics


Rating Metrics

11%

-3%53

Close Chg.

Top Business

53

Chg.


Top Global Print

Top US Newspapers

WW Newspapers

46 -36%

-9%

-1%

4%

Top Healthcare

Top Industrial

Top Services

-2%

0%

Top Technology -12%

2%

43

35

64

1%

84 -2%

-2%

7%

Top Industry

-48%

-2%

-4%


Broadcast

49

59

69

74 92 -12 # 73 96 87 -9# 1%Top Business



�Yr.

�Mo

-36%

+9%


Social Media

Global Web

NOVEMBER

2016

�Yr. -44%

�Yr. -27%

�Mo -15%

�Mo. -11%

Online News

Bayer HealthCare within the Pharmaceutical Brands SectorSegment-Level Media Rating Metrics



46

47

Gai

nin

g M

om

entu

mL

on

g (1

2-M

onth

)Med

ia R

atin

g G

row

th

Bayer HealthCare

-26

-21

-16

-11

-6

-1

+4

+9

+14 LeadingFalling

Lagging Gaining


2 2 1 Pfizer -

3 4 8 Sanofi +1


4 4 4 Novartis -




9 12 7 Roche +3

10 6 5 Allergan -4

10 14 11 Eli Lilly +4

10 9 17 Teva -1

13 9 9 Amgen -4




16 12 2 Valeant -4

18 20 11 Abbott +2


6 70

84

-6%

+1

Bayer HealthCare -33 9

Cur

rent

-6

Current

Month

� Prior


-10%

73 -5%

83 -9%

89

12%

62

-27%

-4%

-4%

-5%

r Yr.

-9%70

Prio

r M

o.

Prio

r Y

r.

Ran

k C

hg.



Rank Comparisons

+062

63 +4 67

�Mo.

�Yr.70

12%

-15%-6 73

�Mo.

-13%

-2%

-13%

65

62 -2 63 -13%

-15%

�Yr.

5%

-18%

0%

-9%

-1%

-7%

1%

-11%

70

67

64 62

63 -4 74

70 -3 72

+1

61-1

-3 70

-2 69

+2 69

+2

68

70

68

�Mo -11%

�Yr. -5%

73 Search Volume

Broadcast

-2 77

69

68

+2 73

-6

70 +6

73

67

Growth

YOY

Trailing 12

Mo.


74

52 -0 54

-1

80 -2

53

81

76

81


-26

-13 -8 -3 +2 +7



62 63


Sentiment Breakout

Bristol-Myers Squibb's topline media rating for November 2016 is 70, a notable +6

change over the prior month value of 64 and a -1 change over the prior-year media


average of 52. Bristol-Myers Squibb's media rating max and min for the trailing 12-month

period are 71 in October 2016 and 61 in May 2016.

Advertising Value: Bristol-Myers Squibb's media rating of 70 translates into a current

month AVE of $297,274, with a trailing 12-month total of $2,412,717.

Ranking: Within the Pharmaceutical Brands sector, Bristol-Myers Squibb is currently

ranked no.6, showing a large +10 rank change over the prior month. Year-over-year,

Bristol-Myers Squibb experienced a notable gain of +9 in the Sector ranking.

Growth Quadrant: For the November 2016 reporting period, Bristol-Myers Squibb is in

the Leading quadrant vis-à-vis its peers, showing a notable +6 change in short term

(prior month) growth and a -1 change in long term (prior year) growth, versus the sector

average.

+6

65

65YTD Avg. Rating



Bristol-Myers Squibb Brands

�






70-1 �

78

882012 2013 2014 2015 2016

100% 0%

70

Sector Average52


Extreme(100)

Weak...(0)



87 76 63 80 24 72 55 - 59

83 81 56 59 31 59 46 - 50

89 83 62 80 29 67 53 - 63

Month Month


Online Sources 44 58 +6 68 80 80 +10

52 64 +6 # 75 84 82 +4

53 74 +13 # 59 86 80 +21

20 31 -7 # 54 70 63 +7

# 84 95 93 +8

42 68 +9 # 79 89 88 +4

43 61 +1 # 64 88 88 +2

32 64 +9

79 89 88 +4

- 98 99 98 -

77 86 -2 # 81 88 86 +1

73 82 -5 # 77 87 85 +1

71 87 +5 # 55 84 84 +9

70 89 -10 # 61 82 81 +6

83 90 +4 # 84 95 93 +8

Low 61

84 81

78

Prior Month

Prior Year


47

Twitter

57

46

Top US

Papers

Search

Vol.

Top

Cons.

Topline

Media Rating

Segments

Global Web

Forums

0%

GroupsTop TradeWW

Papers

Top

Bus.

Global

Web

BlogsOnline

News

AsiaNorth

America

Europe

79 92

85 84 58

88

79 75

64

87 58

93 Current Month

#

#

#

Online News

4%

7%

24 -17%

76#

#

#

#

84


Asia

Twitter

Forums


#

#

Europe

# Blogs

Search Volume

#

1%

3%

Top Business

Top Consumer

North America 87

-12%

-2%

75South America

Segment-Level Media

Rating Metrics


Rating Metrics

2%

0%72

Close Chg.

Top Business

54

Chg.


Top Global Print

Top US Newspapers

WW Newspapers

64 10%

3%

-8%

8%

Top Healthcare

Top Industrial

Top Services

1%

-1%

Top Technology 2%

-1%

55

47

59

1%

80 -5%

1%

-6%

Top Industry

-18%

1%

4%


Broadcast

48

58

68

83 90 +4 # 84 95 93 +8# 1%Top Business



�Yr.

�Mo

+10%

+13%


Social Media

Global Web

NOVEMBER

2016

�Yr. +7%

�Yr. -7%

�Mo +18%

�Mo. +9%

Online News

Bristol-Myers Squibb within the Pharmaceutical Brands SectorSegment-Level Media Rating Metrics



64

54

72

Gai

nin

g M

om

entu

mL

on

g (1

2-M

onth

)Med

ia R

atin

g G

row

th


-26

-21

-16

-11

-6

-1

+4

+9

+14 LeadingFalling

Lagging Gaining


2 2 1 Pfizer -

3 4 8 Sanofi +1


4 4 4 Novartis -




9 12 7 Roche +3

10 6 5 Allergan -4

10 14 11 Eli Lilly +4

10 9 17 Teva -1

13 9 9 Amgen -4




16 12 2 Valeant -4

18 20 11 Abbott +2


6 70

84

-6%

+1

Bristol-Myers Squibb +1016 15

Cur

rent

+6

Current

Month

� Prior


-10%

73 -5%

83 -9%

89

12%

62

-27%

+4%

-29%

-17%

r Yr.

-1%65

Prio

r M

o.

Prio

r Y

r.

Ran

k C

hg.



Rank Comparisons

+062

63 +4 67

�Mo.

�Yr.70

12%

-15%-6 73

�Mo.

-13%

-2%

-13%

65

62 -2 63 -13%

+2%

�Yr.

5%

-18%

0%

-9%

-1%

-7%

1%

-11%

70

67

64 62

63 -4 74

70 -3 72

+1

61-1

-3 70

-2 69

+2 69

+2

68

70

68

�Mo +5%

�Yr. +0%

73 Search Volume

Broadcast

-2 77

69

68

+2 73

-6

70 +6

73

67

Growth

YOY

Trailing 12

Mo.


74

52 -0 54

-1

80 -2

72

82

24

88


-26

-13 -8 -3 +2 +7



62 63


Sentiment Breakout

GlaxoSmithKline's topline media rating for November 2016 is 70, a moderate -3 change

over the prior month value of 73 and a notable -5 change over the prior-year media


average of 52. GlaxoSmithKline's media rating max and min for the trailing 12-month

period are 76 in July 2016 and 70 in October 2015.

Advertising Value: GlaxoSmithKline's media rating of 70 translates into a current month

AVE of $580,319, with a trailing 12-month total of $9,395,684.

Ranking: Within the Pharmaceutical Brands sector, GlaxoSmithKline is currently ranked

no.6, showing a negligible +1 rank change over the prior month. Year-over-year,

GlaxoSmithKline experienced a notable gain of +7 in the Sector ranking.

Growth Quadrant: For the November 2016 reporting period, GlaxoSmithKline is in the

Falling quadrant vis-à-vis its peers, showing a moderate -3 change in short term (prior

month) growth and a notable -5 change in long term (prior year) growth, versus the

sector average.

-3

72

72YTD Avg. Rating



GlaxoSmithKline Brands

�






70-5 �

86

962012 2013 2014 2015 2016

100% 0%

70

Sector Average52

GlaxoSmithKline

Extreme(100)

Weak...(0)



82 87 79 71 52 63 38 - 52

85 89 83 67 56 64 38 - 51

85 92 77 67 48 72 63 - 57

Month Month


Online Sources 45 57 -3 78 84 80 -2

45 64 -4 # 85 90 85 -2

59 72 -1 # 52 76 71 +4

40 56 -4 # 77 86 79 -4

# 90 95 91 -3

32 60 - # 90 96 90 -2

30 51 -10 # 80 92 86 -2

36 59 +1

90 96 90 -2

# 99 100 99 -1

87 94 -4 # 89 96 89 -1

87 95 -2 # 86 95 86 -2

90 95 -3 - 87 94 87 -

78 97 -8 # 90 97 90 -4

82 90 -3 # 90 95 91 -3

Low 70

91 90

92

Prior Month

Prior Year


32

Twitter

49

42

Top US

Papers

Search

Vol.

Top

Cons.

Topline

Media Rating

Segments

Global Web

Forums

-3%

GroupsTop TradeWW

Papers

Top

Bus.

Global

Web

BlogsOnline

News

AsiaNorth

America

Europe

94 93

94 92 54

90

94 94

50

94 65

91 Current Month

#

#

#

Online News

-40%

-13%

52 8%

87#

#

#

#

91


Asia

Twitter

Forums


#

#

Europe

- Blogs

Search Volume

#

-2%

-4%

Top Business

Top Consumer

North America 82

-6%

-4%

87South America

Segment-Level Media

Rating Metrics


Rating Metrics

3%

6%63

Close Chg.

Top Business

48

Chg.


Top Global Print

Top US Newspapers

WW Newspapers

50 -23%

-2%

-5%

-1%

Top Healthcare

Top Industrial

Top Services

-5%

0%

Top Technology -6%

-9%

38

32

52

-2%

87 -3%

-4%

-9%

Top Industry

-35%

-4%

-2%


Broadcast

56

66

76

82 90 -3 # 90 95 91 -3# -2%Top Business



�Yr.

�Mo

-23%

-7%


Social Media

Global Web

NOVEMBER

2016

�Yr. -13%

�Yr. -27%

�Mo -2%

�Mo. -8%

Online News

GlaxoSmithKline within the Pharmaceutical Brands SectorSegment-Level Media Rating Metrics



50

41

63

Gai

nin

g M

om

entu

mL

on

g (1

2-M

onth

)Med

ia R

atin

g G

row

th

GlaxoSmithKline

-26

-21

-16

-11

-6

-1

+4

+9

+14 LeadingFalling

Lagging Gaining


2 2 1 Pfizer -

3 4 8 Sanofi +1


4 4 4 Novartis -




9 12 7 Roche +3

10 6 5 Allergan -4

10 14 11 Eli Lilly +4

10 9 17 Teva -1

13 9 9 Amgen -4




16 12 2 Valeant -4

18 20 11 Abbott +2


6 70

84

-6%

+1

GlaxoSmithKline +17 13

Cur

rent

-3

Current

Month

� Prior


-10%

73 -5%

83 -9%

89

12%

62

-27%

-2%

-8%

+8%

r Yr.

-7%72

Prio

r M

o.

Prio

r Y

r.

Ran

k C

hg.



Rank Comparisons

+062

63 +4 67

�Mo.

�Yr.70

12%

-15%-6 73

�Mo.

-13%

-2%

-13%

65

62 -2 63 -13%

-2%

�Yr.

5%

-18%

0%

-9%

-1%

-7%

1%

-11%

70

67

64 62

63 -4 74

70 -3 72

+1

61-1

-3 70

-2 69

+2 69

+2

68

70

68

�Mo -2%

�Yr. -3%

73 Search Volume

Broadcast

-2 77

69

68

+2 73

-6

70 +6

73

67

Growth

YOY

Trailing 12

Mo.


74

52 -0 54

-1

80 -2

63

85

52

86


-26

-13 -8 -3 +2 +7



62 63


Sentiment Breakout

Roche's topline media rating for November 2016 is 69, a moderate +2 change over the

prior month value of 67 and a large -10 change over the prior-year media rating of 79.


52. Roche's media rating max and min for the trailing 12-month period are 80 in June

2016 and 67 in February 2016.

Advertising Value: Roche's media rating of 69 translates into a current month AVE of


Ranking: Within the Pharmaceutical Brands sector, Roche is currently ranked no.9,

showing a moderate +3 rank change over the prior month. Year-over-year, Roche

experienced a moderate loss of -2 in the Sector ranking.

Growth Quadrant: For the November 2016 reporting period, Roche is in the Gaining

quadrant vis-à-vis its peers, showing a moderate +2 change in short term (prior month)

growth and a large -10 change in long term (prior year) growth, versus the sector

average.

+2

70

70YTD Avg. Rating



Roche Brands

�






69-10 �

83

932012 2013 2014 2015 2016

86% 14%

69

Sector Average52

Roche

Extreme(100)

Weak...(0)



87 86 68 70 78 51 32 - 49

82 84 63 59 79 53 31 - 50

84 84 68 62 69 87 68 - 76

Month Month


Online Sources 44 74 - 71 81 74 +3

48 77 -2 # 79 87 82 +3

48 85 -2 # 59 79 70 +11

70 79 -1 # 63 75 68 +5

# 87 94 93 +5

15 65 +1 # 83 94 88 +5

32 72 +2 - 80 91 87 -

30 75 -1

83 94 88 +5

# 98 99 99 +1

85 92 +2 # 80 93 86 +6

84 90 +2 # 81 92 88 +7

87 92 +3 # 78 92 87 +9

83 96 -3 # 74 92 74 -1

82 90 +5 # 87 94 93 +5

Low 67

90 74

91

Prior Month

Prior Year


38

Twitter

70

36

Top US

Papers

Search

Vol.

Top

Cons.

Topline

Media Rating

Segments

Global Web

Forums

-4%

GroupsTop TradeWW

Papers

Top

Bus.

Global

Web

BlogsOnline

News

AsiaNorth

America

Europe

86 93

88 83 51

88

87 75

49

89 73

93 Current Month

#

#

#

Online News

-53%

-41%

78 13%

86#

#

#

#

90


Asia

Twitter

Forums


#

#

Europe

# Blogs

Search Volume

#

0%

-14%

Top Business

Top Consumer

North America 87

-10%

4%

84South America

Segment-Level Media

Rating Metrics


Rating Metrics

0%

13%51

Close Chg.

Top Business

50

Chg.


Top Global Print

Top US Newspapers

WW Newspapers

49 -33%

-9%

2%

-1%

Top Healthcare

Top Industrial

Top Services

-1%

0%

Top Technology 5%

4%

32

38

49

0%

87 -1%

-1%

-36%

Top Industry

-46%

-1%

-3%


Broadcast

53

63

73

82 90 +5 # 87 94 93 +5# 0%Top Business


North America 87 4%

�Yr.

�Mo

-33%

+3%


Social Media

Global Web

NOVEMBER

2016

�Yr. -41%

�Yr. -44%

�Mo -4%

�Mo. -4%

Online News

Roche within the Pharmaceutical Brands SectorSegment-Level Media Rating Metrics



49

40

Gai

nin

g M

om

entu

mL

on

g (1

2-M

onth

)Med

ia R

atin

g G

row

th

Roche

-26

-21

-16

-11

-6

-1

+4

+9

+14 LeadingFalling

Lagging Gaining


2 2 1 Pfizer -

3 4 8 Sanofi +1


4 4 4 Novartis -




9 12 7 Roche +3

10 6 5 Allergan -4

10 14 11 Eli Lilly +4

10 9 17 Teva -1

13 9 9 Amgen -4




16 12 2 Valeant -4

18 20 11 Abbott +2


9 69

84

-6%

+1

Roche +312 7

Cur

rent

+2

Current

Month

� Prior


-10%

73 -5%

83 -9%

89

12%

62

-27%

-3%

-1%

+13%

r Yr.

-13%70

Prio

r M

o.

Prio

r Y

r.

Ran

k C

hg.



Rank Comparisons

+062

63 +4 67

�Mo.

�Yr.70

12%

-15%-6 73

�Mo.

-13%

-2%

-13%

65

62 -2 63 -13%

+0%

�Yr.

5%

-18%

0%

-9%

-1%

-7%

1%

-11%

70

67

64 62

63 -4 74

70 -3 72

+1

61-1

-3 70

-2 69

+2 69

+2

68

70

68

�Mo +4%

�Yr. -4%

73 Search Volume

Broadcast

-2 77

69

68

+2 73

-6

70 +6

73

67

Growth

YOY

Trailing 12

Mo.


74

52 -0 54

-1

80 -2

51

82

78

87


-26

-13 -8 -3 +2 +7



62 63


Sentiment Breakout

Allergan's topline media rating for November 2016 is 68, a notable -6 change over the



52. Allergan's media rating max and min for the trailing 12-month period are 80 in April

2016 and 68 in July 2016.

Advertising Value: Allergan's media rating of 68 translates into a current month AVE of


Ranking: Within the Pharmaceutical Brands sector, Allergan is currently ranked no.10,

showing a moderate -4 rank change over the prior month. Year-over-year, Allergan

experienced a notable loss of -5 in the Sector ranking.

Growth Quadrant: For the November 2016 reporting period, Allergan is in the Lagging

quadrant vis-à-vis its peers, showing a notable -6 change in short term (prior month)


average.

-6

73

73YTD Avg. Rating



Allergan Brands

�






68-12 �

73

832012 2013 2014 2015 2016

100% 0%

68

Sector Average52

Allergan

Extreme(100)

Weak...(0)



87 81 70 77 66 59 31 - 48

90 84 70 86 70 64 44 - 53

90 83 76 89 42 89 72 - 68

Month Month


Online Sources 46 71 -7 73 90 73 -8

47 83 -6 # 81 93 81 -3

57 89 -5 # 77 96 77 -9

45 94 -4 - 65 90 70 -

# 88 98 92 -2

29 83 -13 # 88 96 88 -2

38 61 -8 # 56 92 56 -32

32 65 -5

88 96 88 -2

- 98 100 99 -

83 95 +1 # 88 95 88 -1

80 92 -3 # 86 96 86 -4

83 95 +1 # 80 94 80 -1

69 97 +9 # 85 94 86 +1

84 96 -3 # 88 98 92 -2

Low 54

89 86

91

Prior Month

Prior Year


38

Twitter

67

46

Top US

Papers

Search

Vol.

Top

Cons.

Topline

Media Rating

Segments

Global Web

Forums

-9%

GroupsTop TradeWW

Papers

Top

Bus.

Global

Web

BlogsOnline

News

AsiaNorth

America

Europe

90 96

94 90 56

88

88 85

50

92 84

92 Current Month

#

#

#

Online News

-57%

-34%

66 57%

81#

#

#

#

89


Asia

Twitter

Forums


#

#

Europe

# Blogs

Search Volume

#

-4%

-4%

Top Business

Top Consumer

North America 87

-16%

-3%

78South America

Segment-Level Media

Rating Metrics


Rating Metrics

-8%

-13%59

Close Chg.

Top Business

49

Chg.


Top Global Print

Top US Newspapers

WW Newspapers

50 -40%

-16%

-2%

-2%

Top Healthcare

Top Industrial

Top Services

-3%

0%

Top Technology -8%

-7%

31

38

48

-4%

84 -6%

-4%

-29%

Top Industry

-43%

-4%

-33%


Broadcast

43

53

63

84 96 -3 # 88 98 92 -2# -4%Top Business



�Yr.

�Mo

-40%

-23%


Social Media

Global Web

NOVEMBER

2016

�Yr. -34%

�Yr. -43%

�Mo -8%

�Mo. -12%

Online News

Allergan within the Pharmaceutical Brands SectorSegment-Level Media Rating Metrics



50

39

Gai

nin

g M

om

entu

mL

on

g (1

2-M

onth

)Med

ia R

atin

g G

row

th

Allergan

-26

-21

-16

-11

-6

-1

+4

+9

+14 LeadingFalling

Lagging Gaining


2 2 1 Pfizer -

3 4 8 Sanofi +1


4 4 4 Novartis -




9 12 7 Roche +3

10 6 5 Allergan -4

10 14 11 Eli Lilly +4

10 9 17 Teva -1

13 9 9 Amgen -4




16 12 2 Valeant -4

18 20 11 Abbott +2


10 68

84

-6%

+1

Allergan -46 5

Cur

rent

-6

Current

Month

� Prior


-10%

73 -5%

83 -9%

89

12%

62

-27%

-33%

-6%

+57%

r Yr.

-15%73

Prio

r M

o.

Prio

r Y

r.

Ran

k C

hg.



Rank Comparisons

+062

63 +4 67

�Mo.

�Yr.70

12%

-15%-6 73

�Mo.

-13%

-2%

-13%

65

62 -2 63 -13%

-57%

�Yr.

5%

-18%

0%

-9%

-1%

-7%

1%

-11%

70

67

64 62

63 -4 74

70 -3 72

+1

61-1

-3 70

-2 69

+2 69

+2

68

70

68

�Mo -4%

�Yr. -9%

73 Search Volume

Broadcast

-2 77

69

68

+2 73

-6

70 +6

73

67

Growth

YOY

Trailing 12

Mo.


74

52 -0 54

-1

80 -2

59

81

66

56


-26

-13 -8 -3 +2 +7



62 63


Sentiment Breakout

Eli Lilly's topline media rating for November 2016 is 68, a moderate +2 change over the



52. Eli Lilly's media rating max and min for the trailing 12-month period are 76 in January

2016 and 63 in December 2015.

Advertising Value: Eli Lilly's media rating of 68 translates into a current month AVE of


Ranking: Within the Pharmaceutical Brands sector, Eli Lilly is currently ranked no.10,

showing a moderate +4 rank change over the prior month. Year-over-year, Eli Lilly

experienced a gain of +1 in the Sector ranking.

Growth Quadrant: For the November 2016 reporting period, Eli Lilly is in the Gaining

quadrant vis-à-vis its peers, showing a moderate +2 change in short term (prior month)


average.

+2

69

69YTD Avg. Rating



Eli Lilly Brands

�






68-8 �

80

902012 2013 2014 2015 2016

89% 11%

68

Sector Average52

Eli Lilly

Extreme(100)

Weak...(0)



88 77 65 83 47 59 41 - 47

82 78 56 71 50 54 39 - 49

91 87 69 85 51 67 62 - 68

Month Month


Online Sources 39 57 - 72 79 76 +3

46 61 -2 # 78 86 81 +3

52 65 +5 # 58 83 83 +12

10 55 -3 # 51 66 65 +9

# 85 93 91 +4

21 69 +2 # 86 93 87 +1

42 49 - # 81 92 81 -6

36 74 -2

86 93 87 +1

- 98 99 98 -

77 89 +5 # 85 92 87 +2

77 87 -1 - 85 91 85 -

75 87 +4 # 75 91 82 +7

74 96 +11 # 79 92 79 -4

82 90 +6 # 85 93 91 +4

Low 63

79 79

86

Prior Month

Prior Year


47

Twitter

46

47

Top US

Papers

Search

Vol.

Top

Cons.

Topline

Media Rating

Segments

Global Web

Forums

-7%

GroupsTop TradeWW

Papers

Top

Bus.

Global

Web

BlogsOnline

News

AsiaNorth

America

Europe

89 95

87 86 52

87

75 83

50

92 57

91 Current Month

#

#

#

Online News

-34%

-12%

47 -8%

77#

#

#

#

79


Asia

Twitter

Forums


-

#

Europe

# Blogs

Search Volume

#

-4%

-11%

Top Business

Top Consumer

North America 88

-11%

-3%

85South America

Segment-Level Media

Rating Metrics


Rating Metrics

-6%

-2%59

Close Chg.

Top Business

48

Chg.


Top Global Print

Top US Newspapers

WW Newspapers

50 -12%

-7%

-11%

-8%

Top Healthcare

Top Industrial

Top Services

-3%

-1%

Top Technology -7%

-4%

41

47

47

-4%

82 -9%

-5%

-31%

Top Industry

2%

-5%

-10%


Broadcast

50

60

70

82 90 +6 # 85 93 91 +4# -4%Top Business



�Yr.

�Mo

-12%

+0%


Social Media

Global Web

NOVEMBER

2016

�Yr. -12%

�Yr. -24%

�Mo +8%

�Mo. -4%

Online News

Eli Lilly within the Pharmaceutical Brands SectorSegment-Level Media Rating Metrics



50

45

Gai

nin

g M

om

entu

mL

on

g (1

2-M

onth

)Med

ia R

atin

g G

row

th

Eli Lilly

-26

-21

-16

-11

-6

-1

+4

+9

+14 LeadingFalling

Lagging Gaining


2 2 1 Pfizer -

3 4 8 Sanofi +1


4 4 4 Novartis -




9 12 7 Roche +3

10 6 5 Allergan -4

10 14 11 Eli Lilly +4

10 9 17 Teva -1

13 9 9 Amgen -4




16 12 2 Valeant -4

18 20 11 Abbott +2


10 68

84

-6%

+1

Eli Lilly +414 11

Cur

rent

+2

Current

Month

� Prior


-10%

73 -5%

83 -9%

89

12%

62

-27%

-10%

-6%

-8%

r Yr.

-11%69

Prio

r M

o.

Prio

r Y

r.

Ran

k C

hg.



Rank Comparisons

+062

63 +4 67

�Mo.

�Yr.70

12%

-15%-6 73

�Mo.

-13%

-2%

-13%

65

62 -2 63 -13%

-7%

�Yr.

5%

-18%

0%

-9%

-1%

-7%

1%

-11%

70

67

64 62

63 -4 74

70 -3 72

+1

61-1

-3 70

-2 69

+2 69

+2

68

70

68

�Mo +4%

�Yr. -7%

73 Search Volume

Broadcast

-2 77

69

68

+2 73

-6

70 +6

73

67

Growth

YOY

Trailing 12

Mo.


74

52 -0 54

-1

80 -2

59

81

47

81


-26

-13 -8 -3 +2 +7



62 63


Sentiment Breakout

Teva's topline media rating for November 2016 is 68, a moderate -2 change over the

prior month value of 70 and a +1 change over the prior-year media rating of 67. This


Teva's media rating max and min for the trailing 12-month period are 74 in June 2016

and 64 in January 2016.

Advertising Value: Teva's media rating of 68 translates into a current month AVE of


Ranking: Within the Pharmaceutical Brands sector, Teva is currently ranked no.10,

showing a negligible -1 rank change over the prior month. Year-over-year, Teva

experienced a notable gain of +7 in the Sector ranking.

Growth Quadrant: For the November 2016 reporting period, Teva is in the Falling


growth and a +1 change in long term (prior year) growth, versus the sector average.

-2

69

69YTD Avg. Rating



Teva Brands

�






68+1 �

81

912012 2013 2014 2015 2016

100% 0%

68

Sector Average52

Teva

Extreme(100)

Weak...(0)



84 87 73 63 79 47 43 - 53

85 86 69 75 76 51 49 - 61

83 88 69 74 17 68 48 - 47

Month Month


Online Sources 40 54 -3 70 82 71 -4

34 51 -4 - 80 88 80 -

47 71 -4 # 60 83 63 -12

64 82 +3 # 61 81 73 +4

- 85 95 88 -

13 49 -6 - 87 94 87 -

22 34 -2 # 74 93 74 -11

33 61 -8

87 94 87 -

- 97 99 98 -

81 92 +3 # 86 93 89 +3

86 92 +1 # 86 92 90 +4

75 89 +3 # 79 92 79 -4

74 96 +7 # 80 93 80 -1

79 93 -1 - 85 95 88 -

Low 64

83 80

84

Prior Month

Prior Year


25

Twitter

39

27

Top US

Papers

Search

Vol.

Top

Cons.

Topline

Media Rating

Segments

Global Web

Forums

-6%

GroupsTop TradeWW

Papers

Top

Bus.

Global

Web

BlogsOnline

News

AsiaNorth

America

Europe

87 90

88 87 44

87

80 81

40

90 54

88 Current Month

#

#

#

Online News

-10%

-31%

79 365%

87#

#

#

#

83


Asia

Twitter

Forums


#

#

Europe

# Blogs

Search Volume

#

-2%

-8%

Top Business

Top Consumer

North America 84

-16%

1%

81South America

Segment-Level Media

Rating Metrics


Rating Metrics

6%

-15%47

Close Chg.

Top Business

48

Chg.


Top Global Print

Top US Newspapers

WW Newspapers

40 -26%

-9%

-1%

-1%

Top Healthcare

Top Industrial

Top Services

-1%

0%

Top Technology -8%

2%

43

25

53

-2%

84 -5%

-3%

13%

Top Industry

-36%

-3%

-11%


Broadcast

51

61

71

79 93 -1 - 85 95 88 -# -2%Top Business


North America 84 1%

�Yr.

�Mo

-26%

-15%


Social Media

Global Web

NOVEMBER

2016

�Yr. -31%

�Yr. -11%

�Mo -9%

�Mo. -10%

Online News

Teva within the Pharmaceutical Brands SectorSegment-Level Media Rating Metrics



40

40

Gai

nin

g M

om

entu

mL

on

g (1

2-M

onth

)Med

ia R

atin

g G

row

th

Teva

-26

-21

-16

-11

-6

-1

+4

+9

+14 LeadingFalling

Lagging Gaining


2 2 1 Pfizer -

3 4 8 Sanofi +1


4 4 4 Novartis -




9 12 7 Roche +3

10 6 5 Allergan -4

10 14 11 Eli Lilly +4

10 9 17 Teva -1

13 9 9 Amgen -4




16 12 2 Valeant -4

18 20 11 Abbott +2


10 68

84

-6%

+1

Teva -19 17

Cur

rent

-2

Current

Month

� Prior


-10%

73 -5%

83 -9%

89

12%

62

-27%

-11%

+4%

+365%

r Yr.

1%69

Prio

r M

o.

Prio

r Y

r.

Ran

k C

hg.



Rank Comparisons

+062

63 +4 67

�Mo.

�Yr.70

12%

-15%-6 73

�Mo.

-13%

-2%

-13%

65

62 -2 63 -13%

-15%

�Yr.

5%

-18%

0%

-9%

-1%

-7%

1%

-11%

70

67

64 62

63 -4 74

70 -3 72

+1

61-1

-3 70

-2 69

+2 69

+2

68

70

68

�Mo +0%

�Yr. -6%

73 Search Volume

Broadcast

-2 77

69

68

+2 73

-6

70 +6

73

67

Growth

YOY

Trailing 12

Mo.


74

52 -0 54

-1

80 -2

47

80

79

74


-26

-13 -8 -3 +2 +7



62 63


Sentiment Breakout

Amgen's topline media rating for November 2016 is 67, a moderate -3 change over the



52. Amgen's media rating max and min for the trailing 12-month period are 77 in July

2016 and 66 in June 2016.

Advertising Value: Amgen's media rating of 67 translates into a current month AVE of


Ranking: Within the Pharmaceutical Brands sector, Amgen is currently ranked no.13,

showing a moderate -4 rank change over the prior month. Year-over-year, Amgen

experienced a moderate loss of -4 in the Sector ranking.

Growth Quadrant: For the November 2016 reporting period, Amgen is in the Lagging



average.

-3

70

70YTD Avg. Rating



Amgen Brands

�






67-10 �

82

922012 2013 2014 2015 2016

100% 0%

67

Sector Average52

Amgen

Extreme(100)

Weak...(0)



85 82 54 63 49 64 40 - 52

89 86 64 79 48 63 36 - 49

89 82 65 83 69 73 58 - 60

Month Month


Online Sources 44 59 +1 71 82 72 -6

44 57 -5 # 80 88 80 -3

56 72 +1 # 60 81 63 -16

48 60 +1 # 50 70 54 -10

# 85 94 92 -1

27 61 +4 # 87 93 87 -1

45 61 +2 # 72 92 84 -6

28 57 +3

87 93 87 -1

# 98 99 98 -1

80 90 - # 90 93 91 +1

81 88 -4 # 88 93 89 -2

82 88 -2 # 78 91 79 +1

57 95 +10 # 75 91 75 -1

84 92 -4 # 85 94 92 -1

Low 66

82 75

85

Prior Month

Prior Year


50

Twitter

65

48

Top US

Papers

Search

Vol.

Top

Cons.

Topline

Media Rating

Segments

Global Web

Forums

-7%

GroupsTop TradeWW

Papers

Top

Bus.

Global

Web

BlogsOnline

News

AsiaNorth

America

Europe

88 92

93 88 54

87

84 76

49

91 57

92 Current Month

#

#

#

Online News

-31%

-12%

49 -29%

82#

#

#

#

82


Asia

Twitter

Forums


#

#

Europe

# Blogs

Search Volume

#

0%

-15%

Top Business

Top Consumer

North America 85

-11%

-4%

84South America

Segment-Level Media

Rating Metrics


Rating Metrics

-17%

-24%64

Close Chg.

Top Business

51

Chg.


Top Global Print

Top US Newspapers

WW Newspapers

49 -14%

-12%

0%

-4%

Top Healthcare

Top Industrial

Top Services

2%

-1%

Top Technology -10%

1%

40

50

52

0%

83 -6%

-4%

-13%

Top Industry

-23%

-4%

-5%


Broadcast

52

62

72

84 92 -4 # 85 94 92 -1# 0%Top Business



�Yr.

�Mo

-14%

+6%


Social Media

Global Web

NOVEMBER

2016

�Yr. -12%

�Yr. -23%

�Mo +2%

�Mo. -10%

Online News

Amgen within the Pharmaceutical Brands SectorSegment-Level Media Rating Metrics



49

47

64

Gai

nin

g M

om

entu

mL

on

g (1

2-M

onth

)Med

ia R

atin

g G

row

th

Amgen

-26

-21

-16

-11

-6

-1

+4

+9

+14 LeadingFalling

Lagging Gaining


2 2 1 Pfizer -

3 4 8 Sanofi +1


4 4 4 Novartis -




9 12 7 Roche +3

10 6 5 Allergan -4

10 14 11 Eli Lilly +4

10 9 17 Teva -1

13 9 9 Amgen -4




16 12 2 Valeant -4

18 20 11 Abbott +2


13 67

84

-6%

+1

Amgen -49 9

Cur

rent

-3

Current

Month

� Prior


-10%

73 -5%

83 -9%

89

12%

62

-27%

-5%

+2%

-29%

r Yr.

-13%70

Prio

r M

o.

Prio

r Y

r.

Ran

k C

hg.



Rank Comparisons

+062

63 +4 67

�Mo.

�Yr.70

12%

-15%-6 73

�Mo.

-13%

-2%

-13%

65

62 -2 63 -13%

-7%

�Yr.

5%

-18%

0%

-9%

-1%

-7%

1%

-11%

70

67

64 62

63 -4 74

70 -3 72

+1

61-1

-3 70

-2 69

+2 69

+2

68

70

68

�Mo -4%

�Yr. -7%

73 Search Volume

Broadcast

-2 77

69

68

+2 73

-6

70 +6

73

67

Growth

YOY

Trailing 12

Mo.


74

52 -0 54

-1

80 -2

64

80

49

84


-26

-13 -8 -3 +2 +7



62 63


Sentiment Breakout

Novo Nordisk's topline media rating for November 2016 is 67, a -1 change over the prior

month value of 68 and a notable +7 change over the prior-year media rating of 60. This


Novo Nordisk's media rating max and min for the trailing 12-month period are 68 in

September 2016 and 55 in April 2016.

Advertising Value: Novo Nordisk's media rating of 67 translates into a current month AVE

of $388,942, with a trailing 12-month total of $3,182,711.

Ranking: Within the Pharmaceutical Brands sector, Novo Nordisk is currently ranked

no.13, showing a moderate -2 rank change over the prior month. Year-over-year, Novo

Nordisk experienced a large gain of +10 in the Sector ranking.

Growth Quadrant: For the November 2016 reporting period, Novo Nordisk is in the

Falling quadrant vis-à-vis its peers, showing a -1 change in short term (prior month)

growth and a notable +7 change in long term (prior year) growth, versus the sector

average.

-1

62

61YTD Avg. Rating



Novo Nordisk Brands

�






67+7 �

64

69

742012 2013 2014 2015 2016

92% 8%

67

Sector Average52

Novo Nordisk

Extreme(100)

Weak...(0)



74 71 56 68 61 65 44 - 47

75 76 54 59 61 62 52 - 59

61 71 48 62 50 4 53 - 56

Month Month


Online Sources 43 59 -3 54 72 72 +2

43 59 -5 - 62 77 77 -

49 68 +3 # 43 68 68 +9

47 64 - # 36 64 56 +2

# 66 91 91 +3

32 58 -8 - 69 84 84 -

43 65 +3 # 52 82 74 -6

33 78 -12

69 84 84 -

# 94 98 95 -3

63 79 -2 # 65 83 83 +3

64 79 -5 # 59 85 83 +4

72 91 -5 # 56 79 74 -5

59 86 +4 # 58 80 75 -5

55 76 -1 # 66 91 91 +3

Low 55

86 75

84

Prior Month

Prior Year


53

Twitter

60

50

Top US

Papers

Search

Vol.

Top

Cons.

Topline

Media Rating

Segments

Global Web

Forums

13%

GroupsTop TradeWW

Papers

Top

Bus.

Global

Web

BlogsOnline

News

AsiaNorth

America

Europe

64 86

88 84 53

84

91 80

48

80 58

91 Current Month

#

#

-

Online News

-17%

1525%

61 22%

71#

#

#

#

86


Asia

Twitter

Forums


#

#

Europe

# Blogs

Search Volume

#

6%

17%

Top Business

Top Consumer

North America 74

8%

21%

78South America

Segment-Level Media

Rating Metrics


Rating Metrics

17%

10%65

Close Chg.

Top Business

53

Chg.


Top Global Print

Top US Newspapers

WW Newspapers

48 -17%

26%

0%

2%

Top Healthcare

Top Industrial

Top Services

5%

-1%

Top Technology -6%

12%

44

53

47

6%

77 7%

5%

-16%

Top Industry

-12%

5%

-4%


Broadcast

44

49

54

59

64

55 76 -1 # 66 91 91 +3# 6%Top Business


North America 74 21%

�Yr.

�Mo

-17%

-13%


Social Media

Global Web

NOVEMBER

2016

�Yr. +1525%

�Yr. -14%

�Mo +5%

�Mo. -10%

Online News

Novo Nordisk within the Pharmaceutical Brands SectorSegment-Level Media Rating Metrics



48

48

65

Gai

nin

g M

om

entu

mL

on

g (1

2-M

onth

)Med

ia R

atin

g G

row

th

Novo Nordisk

-26

-21

-16

-11

-6

-1

+4

+9

+14 LeadingFalling

Lagging Gaining


2 2 1 Pfizer -

3 4 8 Sanofi +1


4 4 4 Novartis -




9 12 7 Roche +3

10 6 5 Allergan -4

10 14 11 Eli Lilly +4

10 9 17 Teva -1

13 9 9 Amgen -4




16 12 2 Valeant -4

18 20 11 Abbott +2


13 67

84

-6%

+1

Novo Nordisk -211 23

Cur

rent

-1

Current

Month

� Prior


-10%

73 -5%

83 -9%

89

12%

62

-27%

-4%

+0%

+22%

r Yr.

12%61

Prio

r M

o.

Prio

r Y

r.

Ran

k C

hg.



Rank Comparisons

+062

63 +4 67

�Mo.

�Yr.70

12%

-15%-6 73

�Mo.

-13%

-2%

-13%

65

62 -2 63 -13%

-8%

�Yr.

5%

-18%

0%

-9%

-1%

-7%

1%

-11%

70

67

64 62

63 -4 74

70 -3 72

+1

61-1

-3 70

-2 69

+2 69

+2

68

70

68

�Mo +0%

�Yr. +13%

73 Search Volume

Broadcast

-2 77

69

68

+2 73

-6

70 +6

73

67

Growth

YOY

Trailing 12

Mo.


74

52 -0 54

-1

80 -2

65

77

61

74


-26

-13 -8 -3 +2 +7



62 63


Sentiment Breakout

Janssen Pharmaceuticals' topline media rating for November 2016 is 64, a +1 change

over the prior month value of 63 and a notable +7 change over the prior-year media


average of 52. Janssen Pharmaceuticals' media rating max and min for the trailing 12-

month period are 66 in December 2015 and 57 in October 2015.

Advertising Value: Janssen Pharmaceuticals' media rating of 64 translates into a current

month AVE of $276,244, with a trailing 12-month total of $47,281,678.

Ranking: Within the Pharmaceutical Brands sector, Janssen Pharmaceuticals is

currently ranked no.15, showing a moderate +4 rank change over the prior month. Year-

over-year, Janssen Pharmaceuticals experienced a large gain of +11 in the Sector

ranking.

Growth Quadrant: For the November 2016 reporting period, Janssen Pharmaceuticals

are in the Leading quadrant vis-à-vis its peers, showing a +1 change in short term (prior

month) growth and a notable +7 change in long term (prior year) growth, versus the

sector average.

+1

63

62YTD Avg. Rating



Janssen Pharmaceuticals Brands

�






64+7 �

64

69

742012 2013 2014 2015 2016

67% 33%

64

Sector Average52

Janssen Pharmaceuticals

Extreme(100)

Weak...(0)



74 81 54 37 21 73 57 - 58

78 72 50 37 21 72 54 - 57

71 68 39 32 10 73 56 - 56

Month Month


Online Sources 53 66 +1 59 69 62 -

62 74 -2 # 67 76 68 -2

63 74 +1 - 35 55 37 -

12 25 - # 41 55 54 +4

# 73 85 74 -6

41 99 +3 # 68 77 69 -5

58 88 +2 # 72 89 85 +13

43 65 +1

68 77 69 -5

- 96 98 97 -

69 82 -3 # 62 82 62 -3

64 81 +9 # 55 83 83 +3

71 83 -2 # 46 73 47 -18

56 82 -17 # 39 70 51 -9

74 84 -4 # 73 85 74 -6

Low 56

76 51

77

Prior Month

Prior Year


85

Twitter

57

83

Top US

Papers

Search

Vol.

Top

Cons.

Topline

Media Rating

Segments

Global Web

Forums

3%

GroupsTop TradeWW

Papers

Top

Bus.

Global

Web

BlogsOnline

News

AsiaNorth

America

Europe

52 71

80 74 69

69

78 60

67

70 60

74 Current Month

#

#

-

Online News

2%

0%

21 110%

81#

#

#

#

76


Asia

Twitter

Forums


#

#

Europe

# Blogs

Search Volume

#

4%

-2%

Top Business

Top Consumer

North America 74

-9%

4%

60South America

Segment-Level Media

Rating Metrics


Rating Metrics

38%

16%73

Close Chg.

Top Business

60

Chg.


Top Global Print

Top US Newspapers

WW Newspapers

67 12%

9%

19%

-1%

Top Healthcare

Top Industrial

Top Services

-7%

0%

Top Technology -24%

17%

57

85

58

4%

73 4%

-1%

4%

Top Industry

49%

-1%

10%


Broadcast

44

49

54

59

64

74 84 -4 # 73 85 74 -6# 4%Top Business


North America 74 4%

�Yr.

�Mo

+12%

+3%


Social Media

Global Web

NOVEMBER

2016

�Yr. +0%

�Yr. +20%

�Mo +1%

�Mo. -3%

Online News

Janssen Pharmaceuticals within the Pharmaceutical Brands SectorSegment-Level Media Rating Metrics



67

67

73

Gai

nin

g M

om

entu

mL

on

g (1

2-M

onth

)Med

ia R

atin

g G

row

th

Janssen Pharmaceuticals

-26

-21

-16

-11

-6

-1

+4

+9

+14 LeadingFalling

Lagging Gaining


2 2 1 Pfizer -

3 4 8 Sanofi +1


4 4 4 Novartis -




9 12 7 Roche +3

10 6 5 Allergan -4

10 14 11 Eli Lilly +4

10 9 17 Teva -1

13 9 9 Amgen -4




16 12 2 Valeant -4

18 20 11 Abbott +2


15 64

84

-6%

+1

Janssen Pharmaceuticals +419 26

Cur

rent

+1

Current

Month

� Prior


-10%

73 -5%

83 -9%

89

12%

62

-27%

+10%

+0%

+110%

r Yr.

12%62

Prio

r M

o.

Prio

r Y

r.

Ran

k C

hg.



Rank Comparisons

+062

63 +4 67

�Mo.

�Yr.70

12%

-15%-6 73

�Mo.

-13%

-2%

-13%

65

62 -2 63 -13%

+15%

�Yr.

5%

-18%

0%

-9%

-1%

-7%

1%

-11%

70

67

64 62

63 -4 74

70 -3 72

+1

61-1

-3 70

-2 69

+2 69

+2

68

70

68

�Mo -3%

�Yr. +3%

73 Search Volume

Broadcast

-2 77

69

68

+2 73

-6

70 +6

73

67

Growth

YOY

Trailing 12

Mo.


74

52 -0 54

-1

80 -2

73

68

21

85


-26

-13 -8 -3 +2 +7



62 63


The What, Why and How of mediaQuant’s Measurement Methodology

Question Answer

What are you measuring? The media prominence of a trend, brand or influencer.

Embracing the universal management adage that "you can't manage what you can't measure," the goal of

mediaQuant is to provide a simple, universal measurement of a topic's prominence in traditional, online, and social

media and provide valuable insight into the brands, trends and influencers affecting businesses and markets.

Why are you measuring? To create a universal standard or "ruler" of media prominence with which business professionals can establish

benchmarks, make comparisons, monitor change, and assign value.

Our overriding goal at mediaQuant is to deliver an expansive, consistent and comparable measure of media

prominence for a growing catalog of topics discussed in traditional, online, and social media. Why we measure in the

way we do is to address the need to simplify and standardize media measurement, making it easy to understand,

portable and affordable.

In our varied experience doing market and media research, a pervasive drawback to available media measurement

solutions has been the lack of comparative or contextual analysis capabilities. That is, the ability to assign relative

importance to a given measurement. How high is high? How significant is it? Is it weak or strong compared to its peer

group? With a plethora of media measurement solutions on the market, not to mention countless in-house solutions,

there are hundreds of incompatible ways to measure media prominence. You can’t determine "how good is good"

without a standard ruler of measurement that can be consistently applied across media sources, time periods and

intended audiences.

How are you measuring? We apply the same proven methodology to a vast catalog of current, new and emerging topics discussed in traditional,

online, and social media segments to build a multi-year analytic history and establish comparative ranks on a 100-

point scale.

Because we measure, validate, and index the broadest and most diverse collection of global content and media

sources using a consistent methodology, we are able to create an expansive and statistically representative data set

of media prominence with historical context going back four years. From this data set, we then calculate a media

prominence score between 0 and 100 using a ranking algorithm to transform a raw value into a comparative score.

When new topics or new media sources are added to the catalog, historical values are recalibrated to correctly

account for past historical impact on existing topics.

Over what timeframe is the

media prominence measured?

Calendar month. Historical data is captured back to a trailing 4-year period.

12AM U.S. Eastern time on the first day of the month to 12AM U.S. Eastern Time on the last day of the month.

How do you calculate and

represent media prominence?

We calculate media prominence by measuring the volume of media mentions of a selected topic, assessing the

relative importance of those mentions, and then ranking the weighted value relative to other values in our data set.

The resulting media rating serves as a standard and comparative benchmark of the broad discussion of and relative

interest in trends, brands and influencers discussed in print, broadcast and online media.

A topic's media prominence rating is a statistical rank relative to the other values in the data set and is represented as

a whole number between 0 and 100. This ranked score tells us what percentage of data values scored at or below the

data value under consideration. This is typically how standardized test scores are demonstrated.

For each measured topic, we calculate a topline media rating to provide the best overall measure of media

prominence, as well as individual segment-level media ratings to provide specific context and granularity. We'll

elaborate first on the segment-level media rating, since the weighted average of 15 of the 20+ segment-level ratings

are used to calculate the topline media rating.

The segment-level media rating for a topic is the rank of the topic's mention volume within a particular media

segment (e.g., blogs) relative to all the other (3,500+) measured topics' mention volumes within that same segment.

We measure and report on segment-level media ratings for more than 20 media segments culled from more than

20,000 news sources. (see next page).

We research new information sources on an ongoing basis and add new media segments after careful validation and

benchmarking. Media segments include:

Traditional Online

Print Broadcast Global Web

Newspapers – Worldwide Television – Major U.S. Networks Online News

Newspapers – Top U.S. Search Volume

Newspapers – Top Global Regional

Magazines – Top Consumer North America Social

Magazines – Top Business Europe Consumer Groups

Magazines – Top Healthcare Asia Blogs

Magazines – Top Industrial South America Twitter

Magazines – Top Services Forums

Magazines – Top Technology

The topline media rating for a topic, shown prominently in the upper left of each report page one, is the best

representation of overall media prominence. It is calculated as a weighted average of 15 of the 20+ segment-level

media ratings, grouped within three impact dimensions of earned media coverage as follows:

Regional Prominence Editorial Prominence Online/Viral Prominence

1. North America

2. Europe

3. Asia

4. Worldwide Newspapers

5. Top U.S. Newspapers

6. Top Consumer Print Media

7. Top Business Print Media

8. Top Trade* Print Media

* Healthcare + Industrial + Services + Tech.

9. Global Web (all publicly accessible sites)

10. Search Volume (major search engines)

11. Online News

12. Blogs

13. Consumer Groups

14. Forums

15. Twitter

What media sources do you

use?

From traditional print publications to the latest social media discussions, our universe of earned media content is

unparalleled at more than 20,000 news sources. For traditional media sources, we go to established print and

broadcast media aggregators that maintain historical archives and current feeds. We supplement the aggregators'

content with our own sourcing methods to further complete a global media picture. For social media sources, we use a

combination of real-time feeds, domain-specific indexing and historical archives. We continually research new media

sources, beta-test them and incorporate them into our production measurement methodology as appropriate. (Note

that only English-language content, original or translated, is included.)

What topics are you

measuring and how do you

determine what you measure?

We measure topics along three categories: (1) trends, (2) brands and (3) influencers (people or organizations). Within

those categories, we group topics (e.g., Wind Power) into logical sectors (e.g., Energy) to align with established

industries and market segments. A topic (e.g., Wind Power) may reside in more than one sector (e.g., Energy,

Environment).

Sectors are defined using a blend of top-down and bottom-up approaches. We start with a top-down review of

schemas from established research suppliers. We combine this with bottom-up input gleaned from content clustering

patterns, editorial review, and subscriber feedback. We also include related, tangential topics within a sector in order

to provide additional context and comparisons. In addition, we measure a broad range of sector topics to ensure the

percentile ranking has statistical relevance along a representative continuum of topics discussed in the media.

We expand our catalog of trends, brands and influencers every month. See list of tracked topics at

http://www.mediaquant.net/resources/trend-catalog/

How do you measure

sentiment?

Sentiment measures are based upon the volume of mentions of the target topic that fall into one of two mutually

exclusive sentiment categories: positive or negative. Neutral sentiment is discarded, considered neither positive nor

negative. Category assignment is based upon the prominence (volume + relative importance) of industry-standard

"positive" or "negative" terms or phrases and their proximity to the topic mention. We use the OpenNLP methodology

to facilitate term/phrase categorization.

How do you calculate AVE

(advertising value equivalent)

for brands?

AVE is typically only computed for brands or influencers, which may include corporations, products, or people.

We start with the average theoretical AVE for the month. This is a function of effective reach, average CPM (cost per

thousand), and mention volume. This is calculated across each media segment and summed. We then apply weights,

based on relevant media dynamics, to the theoretical AVE to arrive at the actual AVE. These weights may increase or

decrease the monetized value of the mention.

pharmaceutical brands 52 - mediaquant · 56 +3 +5% +13 +12% purdue pharma 42-6 -13% 602 ... for the...

Documents